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ABSTRACT

Arsenic, a ubiquitous environmental contaminant, is known to cause
immunotoxicity. However, the mechanisms of arsenic induced immunotoxicity are still
not clear. Arsenite (As+3), the trivalent inorganic form of arsenic, was found to increase
DNA damage and inhibit PARP activity in thymus cells at 50 nM in vitro. Oxidative
stress and double strand breaks (DSBs) formation occurred in thymus cells exposed to
As+3 at 500 nM. The genotoxicity was found to be related to As+3 exporter expressions
and reversed by zinc supplement. IL-7 signaling, the critical cytokine signal for the early
DN thymic T cell proliferation, was found to be suppressed by As+3 at 500 nM and
MMA+3 at 50 nM in vitro. The suppressive effects reduced the cell cycle gene expression.
After 30 d in vivo exposure of up to 500 parts per billion (ppb) As+3, thymus cells
were found to contain the higher levels of arsenic than bone marrow and spleen cells.
Correlations between intracellular arsenic concentrations and the increase of DNA
damage were found in both the bone marrow and thymus, but not the spleen.
v

Monomethylarsonous acid (MMA+3) was also found to be more genotoxic than As+3 in
vitro in bone marrow, spleen and thymus, and was demonstrated to be the most prevalent
form of arsenic in bone marrow and thymus after in vivo exposures.
Benzo(a) pyrene-7,8-dihydrodiol (BP-diol), the metabolite of benzo(a) pyrene
(BaP) was found to interact with As+3 synergistically at low concentrations to increase
the DNA damage and inhibit PARP activity in primary thymus cells. The interactive
effects were also demonstrated to increase the expression of CYP1A1 and CYP1B1, two
critical enzymes for the metabolism of BP-diol to the DNA adduct forming compound,
benzo(a) pyrene-7,8-dihydrodiol-9,10-epoxide (BPDE).
The differential sensitivity to As+3 of double negative (DN) and double positive
(DP) thymus cell subsets was also evaluated and compared. Higher intracellular
accumulation of As+3 was found in DN cells, with the higher DNA damage than DP cells
after in vitro As+3 treatments. The expressions of two As+3 exporters, Mdr1 and Mrp1,
were shown to be inversely correlated with the selective genotoxicity in DN cells.
These studies contributed to our understanding of the mechanisms associated with
the toxicity induced by environmentally relevant concentrations of arsenic and its
potential interactions with other environmental contaminants.
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CHAPTER 1

GENERAL INTRODUCTION

1

GENERAL INTRODUCTION

T cell development in thymus
T cells originate from hematopoietic stem cells in the bone marrow and are
transported into the thymus for development. The thymus is a pink-colored, two lobed
organ located between the heart and the sternum. The size of the thymus grows bigger
until adolescent periods. Thymus atrophy occurs physiologically and the stromal tissue of
the thymus starts to be replaced by fat after adolescence. Although T cell lymphopoiesis
lasts throughout adult life, it becomes less and less active with aging (Palmer, 2013).
The earliest T cells in thymus are double negative for both CD4 and CD8 cell
surface markers, which are classified as double negative (DN) cells. Once the functional
T cell receptor (TCR) β chain is formed, the cells are advanced to a double positive
(CD4+, CD8+, DP) stage. DP cells are presented with self-antigens by the major
histocompatibility complexes (MHCs) of the thymic cortical epithelial cells. Only those
DP cells that can interact well (not too strongly or too weakly) with MHC molecules can
receive a survival signal. All the other DP cells will undergo apoptosis. The process is
called positive selection, which ensures that only the functional early T cells can survive
and advance to CD4 or CD8 single positive (SP) stage. CD4SP and CD8SP cells are then
moved to the thymic medulla. Medullary thymic epithelial cells and thymic dendritic
cells present self-antigens on MHC class I (for CD8SP cells) and MHC class II (for
CD4SP cells) molecules. SP cells that overreact with the self-antigens receive apoptotic
signals. The process is called negative selection, which prevents autoimmunity. These
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selection processes together make sure that only the functional and self-tolerant T cells
are produced and released from the thymus (Klein et al., 2014).
Based on the specific cell surface marker expressions of developing T cells at
different stages, we can easily differentiate DN, DP and SP thymic T cell populations by
cell surface marker staining and flow cytometry (Fig 1.1). CD3 is an important part of
TCR signaling complex, which is expressed on the cell surface from late stage DN cells
to mature T cells (). CD4 and CD8 can be used to separate DN, DP, CD4SP and CD8SP
cell populations. The DN cell population can also be further differentiated in to DN1,
DN2, DN3 and DN4 subsets, using cell surface markers CD25 and CD44.
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Figure 1.1. Specific cell surface markers on developing thymic T cells. T cells are
originated from bone marrow and transferred in to the thymus at DN1 stage. DN1, DN2,
DN3 and DN4 cells can be differentiated by CD25 and CD44/CD127 (IL-7 receptor).
DN, DP, CD4SP and CD8SP cells can be differentiated by CD4 and CD8. CD3 starts to
be expressed on the thymic T cell surfaces from the DN3 stage.
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Arsenic metabolism and distribution in vivo
Millions of people around the world are exposed to arsenic, a ubiquitous food and
drinking water contaminant. The trivalent inorganic form of arsenic, arsenite (As+3), and
the pentavalent inorganic form of arsenic, arsenate (As+5), are the common contaminants
in groundwater. These inorganic forms of arsenic is classified as group I carcinogens by
The International Agency for Research on Cancer (IARC). The metabolism pathway of
inorganic arsenical species has been studied and revealed by many research groups
(Drobna et al., 2009; Vahter and Concha, 2001). As shown in Fig 1.2, arsenite
methyltransferase (AS3MT) is a critical enzyme for the metabolism and detoxification of
arsenic in vivo. Variations in the AS3MT gene between individuals play an important role
in the differential sensitivity of cells and tissues to arsenic-induced toxicity (Douillet et
al., 2016). Previous studies have also demonstrated that the intermediate monomethylated
form of arsenite, monomethylarsonous acid (MMA+3), is more toxic than the inorganic
form, As+3. The dimethylated forms of arsenic have relatively limited toxicities compared
to other forms of arsenic (Gusman et al., 2013; Sun et al, 2014).
Studies on arsenic in vivo distribution revealed that the amounts of arsenic in
different organs varied after acute and chronic exposures in humans and animals. Early
literature from legal investigations showed that the arsenic accumulates in the liver after
acute high-dose exposures (Underhill, 1914). Another more recent case revealed that
most of the arsenic was distributed in the liver after acute exposure, followed by the
kidney, heart and spleen (Benramdane et al., 1999). A 90 d in vivo study with 10-60 ppm
arsenite in drinking water on Wistar Albino rats demonstrated that more arsenic
accumulated in the spleen than kidney and heart, and there was no significant increase of
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arsenic accumulations in the spleen with increasing doses (Al-Forkan et al., 2016).
Knockout of AS3MT was showed to increase arsenic accumulation and toxicity in mice
(Hughes et al., 2010). More studies need to be done on the arsenic distribution and
speciation in the immune organs after in vivo exposure to understand mechanisms of
toxicity and differential sensitivity of tissues.
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Figure 1.2. Biotransformation of inorganic arsenical species in mammals. AS3MT,
arsenite methyltranserase, is the critical enzyme in the metabolism of inorganic and
mono-methylated arsenical species. The inorganic forms of arsenic, arsenate (As+5) and
arsenite (As+3) are metabolized into dimethylated forms and excluded from the body.
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Arsenic immunotoxicity and thymic toxicity
Arsenic is known to cause deleterious effects on the immune system. In vivo
studies have demonstrated that arsenic exposure can induce oxidative stress and
inflammation (Dutta et al., 2015; Flora et al., 2007). The functions of T cells, B cells, NK
cells and macrophages were also showed to be suppressed by arsenic both in vivo and in
vitro (Dangleben et al., 2013). A simplified scheme of the general arsenic effects on the
immune system is demonstrated in Fig 1.3. Reduced immune surveillance may contribute
to the carcinogenesis and other arsenic-related diseases.
Many previous arsenic immunotoxicity studies focused on high concentrations
(Ahmed et al., 2014; Patra et al., 2013; Sakurai et al., 2004). It is uncommon that people
can be exposed to arsenic at ppm levels. Our previous studies have demonstrated that
arsenic can cause immunosuppression at extremely low concentrations. 500 nM As+3 was
showed to suppress the functions of immune cells from mouse spleen (Li et al., 2010).
The proliferation of the early B cells in bone marrow was also showed to be suppressed
by As+3 at 50 nM (Ezeh et al., 2014). Dose-dependent suppression was also observed at
~0.1–10 ppb As+3 concentrations in human peripheral blood T cells in some individuals
(Burchiel et al., 2014). These findings not only identified the immunotoxicity of arsenic
at low concentrations, but also support the idea that more immunotoxicity studies on
arsenic should be conducted at low concentrations within the nanomolar range.
Since the early T cells mature in the thymus, the alterations on T cells caused by
arsenic may take place on the developing T cells in the thymus. Epidemiology and animal
studies have revealed that arsenic can cause thymic atrophy, induce oxidative stress in
thymus cells and alter cell cycle related gene expression (Table 1.1). These studies
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revealed the toxic effects of arsenic to the thymus cells. However, the doses of arsenic
applied in most of these animal studies were higher than environmentally relevant
concentrations.
Many studies revealed that thymic dysfunction could result in T cell-based
immunodeficiencies (Amariglio et al., 2010; Jeong et al., 2015; Nunes-Alves et al.,
2013). The toxicity induced by arsenic in the early developing thymic T cells may affect
the matured T cells at later stages. Studies have demonstrated that arsenic suppressed the
proliferation and function of human T cells (Burchiel et al., 2014; Hernández-Castroet al.,
2009; Morzadec et al., 2012). A study on a New Hampshire pregnancy cohort revealed
that in utero arsenic exposure could alter the cytokine secretion of the T cells from the
neonates’ cord blood (Nadeau et al., 2014). Another study compared the T cell
proliferation and cytokine secretion between 20 arsenic exposed individuals and 18
arsenic unexposed individuals indicated that 200 ppb arsenic exposure from drinking
water significantly suppressed the T cell secretion of IFN-γ, IL2, IL10, IL5, and IL4
(Biswas et al., 2008). These studies provided evidence that the arsenic induced
suppression on the matured peripheral T cells may result from the arsenic toxicity on the
early developing thymic T cells.
The current known mechanisms of arsenic toxicity include the suppression of
DNA repair, induction of oxidative stress, alteration of cellular signaling, and epigenetic
modifications (Dangleben et al., 2013). These mechanisms, except the epigenetic
modifications, will be explored in this project.
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Figure 1.3. Arsenic induced immunotoxicity. Arsenic can cause oxidative stress and
induce apoptosis in multiple types of immune cells. Arsenic exposure is also known to
suppress the functions of T cells, B cells macrophages and NK cells. These effects
together contribute to reduced immune surveillance.
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Table 1.1. Epidemiology and animal studies conducted by other groups on arsenic
induced thymic toxicity.
Exposure
Urinary arsenic
4–1126 ppb
Placenta arsenic
17–598 ppb
Exposure
6.66 mg/kg
10 mg/kg

Human in utero exposures
Country
Cohort
Effects
Bangladesh
130 women and
Thymus
their kids
atrophy
Bangladesh
286 women and
Decreased
their kids
sjTRECs1
levels
Animal in vivo studies
Length
Species
Effects
4 wks, 5 d/wk
4 wk old Male
Thymus
Wistar rats
atrophy
7d

5 wk old male
C57BL/6J mice

Reference
Raqib et al,
2009
Ahmed et al,
2012
Reference
Schulz et al,
2002

Cell cycle gene
Nohara et al,
expression
2008
decrease
5 mg/kg
6, 12, 24, 48
7 wk old female
Thymus
Duan et al.,
and 72 h
C57/BL6 and
atrophy,
2015
KM mice
oxidative stress
1. sjTREC are the index to measure the developing T cell function in thymus
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Poly(ADP-Ribose) polymerase (PARP) inhibition by arsenic
The PARP family comprises 17 members, and play important roles in DNA repair
and cell survival regulation (Jubin et al., 2016). PARP1 is the most important member in
the PARP family for DNA repair, since the activation of some other PARP family
proteins, like PARP2, is dependent on PARP1 activation (Beck et al., 2014). PARP1 is a
zinc finger protein and the initiator of the base excision repair (BER) for single strand
breaks (SSBs). PARP1 is also known to participate in the repair of double strand breaks
(DSBs) caused by oxidative damage. The DNA binding domain of PARP1 contains two
C3H1 zinc fingers. Besides its role in DNA repair, PARP1 is also involved in caspaseindependent programed cell death (Los et al., 2002). Studies also revealed that PARP1
activation plays a role in the induction of asthma and autoimmune conditions (Virág,
2005). Some PARP1 inhibitors have been found in clinical trials to induce apoptosis in
cancer cells (Cepeda et al., 2006).
PARP1 is known to be inhibited by As+3, which can disrupt the coordination
sphere in the zinc finger environment of the PARP1 DNA binding domain, and replace
the zinc in the zinc finger (Zhou et al., 2011). As+3 can interact with C3H1 and C4 zinc
fingers and MMA+3 is known to interact with C2H2, C3H1 and C4 zinc fingers (Zhou et
al., 2014). In addition to its ability to replace zinc in the zinc fingers of PARP1, both As+3
and MMA+3 can induce oxidative stress in cells at high concentrations (Qin et al., 2008).
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) can also inhibit
PARP1 activity (Zhou et al., 2011; 2016). Therefore, the dual actions of arsenic at low
and high concentrations are considered to be the major mechanisms of PARP1 inhibition
(Fig 1.4). There is evidence that DNA damage caused by spontaneous base loss and ROS
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are repaired by BER (Carrozza et al., 2009). Inhibition of the PARP1, one of the key
factors in BER, will leave the damaged DNA damage unrepaired, leading to DSBs with
DNA replication (Zharkov, 2008). There is also evidence showing that PARP1
contributes to the activity other DNA repair protein such as XPA, which is an important
factor for the repair of DSBs (King et al., 2012).
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Figure 1.4. Dual actions of arsenic in the inhibition of PARP1. Arsenic at low doses
replaces the zinc (Zn+2) on the zinc fingers of the PARP1 DNA binding domain. Arsenic
at high doses can also generate ROS, in addition to the direct replacement of Zn+2. Both
Zn+2 loss and ROS production causes DNA damage increase in cells.
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Suppression of common γ chain receptor signaling by arsenic: IL-7 signaling in
thymus cell development
The common γ chain, also known as IL-2 receptor subunit gamma, is a cytokine
receptor subunit that is found to be associated with IL-2, IL-4, IL-7, IL-9, IL-15 and IL21 receptors (Asao et al., 2001; Noguchi et al., 1993; Russell et al., 1993; Takeshita et al.,
1992). The signaling of these cytokine receptors is known to involve janus kinases
(JAKs) and signal transducer and activator of transcriptions (STATs). Many studies have
demonstrated that the common γ chain receptors can be suppressed by arsenic. In patients
with adult T-cell leukemia, arsenic treatments were found to decrease IL-4 signaling
(Kchour et al., 2013). IL-2 and IL-4 signaling was also demonstrated to be suppressed by
As+3 at high concentrations (Cheng et al., 2004; Choudhury et al., 2016). Although the
mechanism of the common γ chain receptor signaling suppression by arsenic is still not
clear, studies revealed that As+3 and MMA+3 inhibited the phosphorylation of JAKs and
STATs, the important downstream factors in the signal transduction (Cheng et al., 2004;
Ezeh et al., 2016).
IL-7 is secreted by stromal cells in bone marrow and thymus cortex. IL-7
signaling is required for the development of the early thymic T cells (Namen et al., 1988).
The conversion of the DN cells to DP cells is showed to be controlled by the IL-7
signaling (Boudil et al., 2015). In the IL-7 signaling pathway, the binding of IL-7 to IL-7
receptor leads to a cascade of signals involving JAK1, JAK3 and STAT5 (Fig 1.5).
STAT5 is phosphorylated by phospho-JAK1 (pJAK1), and phospho-STAT5 (pSTAT5) is
stabilized by phospho-JAK3 (pJAK3) (Haan et al., 2011). Previous studies in our lab
revealed that trivalent forms of arsenic can decrease pSTAT5 in pre-B cells in bone
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marrow, inhibiting the transcriptions of cell proliferation genes like PAX5 (Ezeh et al.,
2016). Since IL-7 signaling is critical for DN T cell development, the suppression of IL-7
signaling by arsenic may be a mechanism of arsenic-induced immunotoxicity to the early
T cells. Therefore, the non-genotoxicity study will be focused on whether arsenic can
suppress the IL-7 signaling on DN cells in thymus.
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Figure 1.5. The IL-7 receptor signaling pathway. The IL-7 receptor has an α chain and a
common γ chain (γc). JAK1 and JAK3 are phosphorylated by the IL-7 receptor after the
binding of IL-7 cytokine to the receptor. STAT5 is phosphorylated by pJAK1 and the
phosphorylation is stabilized by pJAK3. Phosphorylated STAT5 is the transcriptional
factor for many cell proliferation and cell cycle genes.
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Arsenic efflux transporters in eukaryotic cells
There are many studies on arsenic toxicity in different organs and cells. However,
few studies have addressed one fundamental question- when cells are exposed to arsenic,
how much arsenic can really get into the cells? Aquaglyceroporins (AQPs) play a central
role in the uptake or As+3 into cells. Phosphate transporters are the major importers of
As+5 (DiTusa et al., 2016). The organic anion transporting polypeptides (OATP1B1,
OATP1B2) and the glucose permeases (GLUT1, GLUT2, GLUT5) are also important
importers of As+3 (Calatayud et al., 2012; Jiang et al., 2010; Leung et al., 2007; Liu et
al., 2004). While the multidrug resistance transporters and the multidrug resistanceassociated transporters, Mdr1 (Abcb1, P-gp1) and Mrps (ABCCs) are known exporters of
inorganic As+3, the AQP9 and GLUT2 transporters are also demonstrated to be
responsible for the transportation of MMA+3 and DMA+3 out of the cells (Drobná et al.,
2020; Liu et al., 2006). There is also evidence showing that the exportation of As+3 by
Mrps requires the conjugation with glutathione (GSH), and the exportation by Mdr1 is
GSH –independent (Maciaszczyk-Dziubinska et al., 2012). An overview of the current
understanding of arsenic transporters (importers and exporters) is presented in Fig 1.6.
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Figure 1.6. Arsenic transporters in immune cells. Uptake of As+5 is mediated by
phosphate transporter(s). AQPs, GLUTs and OATPs are the known importers of As+3.
Mrp1 is expressed by immune cells and exports GSH conjugated As+3. Mdr1 is a GSH
independent exporter of As+3. MMA+3 is exported by certain AQPs and GLUTs. MMA+5
and DMA+5 are transported out of the cell by GLUTs.
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Benzo(a) pyrene (BaP) metabolism and immunotoxicity
BaP, a well-studied polycyclic aromatic hydrocarbon (PAH), is a group I
carcinogen, as classified by International Agency for Research on Cancer (IARC). BaP is
known to cause colon and other cancers in humans (Le Marchand et al., 2002). BaP is a
pro-carcinogen that requires metabolism by three enzymes, CYP1A1, CYP1B1 and
epoxide hydrolase (Jones et al., 1995; Shimada and Fujii-Kuriyama, 2004). When BaP
gets into the human body, it is first transformed into benzo(a) pyrene-7,8-dihydrodiol
(BP-Diol), which is then converted into benzo(a) pyrene-7,8-dihydrodiol-9,10-epoxide
(BPDE) (Fig 1.7). BPDE can covalently bind to DNA, forming DNA adducts which
induce single and double strand DNA breaks (Kim et al., 1998; Schwarz et al., 2001).
Many studies have demonstrated that BaP exposure can cause immunotoxicity (Li
et al., 2010; Rodríguez-Fragoso et al., 2009). BaP in vivo exposure at 3 mg/kg for 35 d
was found to cause thymus atrophy and decrease in lymphocyte numbers and antibody
secretions (De Jong et al., 1999). Similar suppressive effects on immune functions were
also found in mice and fish after exposures to BaP or its metabolites (Carlson et al., 2004;
Schellenberger et al., 2009). An in vitro study on BaP toxicity using primary mouse
immune cells revealed that the BaP adduct formation and cytotoxicity are correlated with
the suppressive effects on spleen cell functions (Ginsberg et al., 2009). These
immunotoxic effects of BaP may be strengthened when combined with arsenic at certain
concentrations.
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(https://en.wikipedia.org/wiki/Benzo(a)pyrene)
Figure 1.7. Metabolism of BaP in vivo. BaP is metabolized to the epoxide form by
CYP1A1 and CYP1B1. Epoxide hydrolase is required to form BP-Diol. BP-Diol is also
metabolized to BPDE by CYP1A1 and CYP1B1.
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Arsenic and polycyclic aromatic hydrocarbon (PAH) interactions
Previous studies have demonstrated that arsenic can interact with many other
environmental agents, such as UV light (Cooper et al., 2009, 2013; Evans et al., 2004;
Zhou et al., 2011). Since polycyclic aromatic hydrocarbons (PAHs) are ubiquitous
pollutants in the environment, it is common that arsenic and PAH co-exposure can occur.
Many studies have addressed the concerns about arsenic and PAH interactions. A study
on smokers from arsenic polluted areas showed that As+3 exposure in drinking water was
related to the increased risk of lung cancer (Hertz-Piccioto et al., 1992). Increased adduct
formation was also found in the lung and skin tissues from As+3 and BaP co-exposed
mice (Evans et al., 2004). A study using mouse hepatocytes indicated that As+3
potentiated the genotoxicity induced by BaP (Maier et al., 2002). Previous studies in our
laboratory demonstrated that combined exposures of low doses of As+3 and PAHs
suppressed the T-dependent antibody responses in mouse splenocytes (Li et al., 2010). A
more recent study also showed that low doses of As+3 and MMA+3 interacted with
extremely low doses of Dibenzo[def, p]chrysene (DBC) synergistically to suppress
mouse bone marrow lymphoid progenitor cells (Ezeh et al., 2015). These studies
indicated that arsenic and certain PAHs may be interactive at low concentrations and
induce synergistic genotoxicity to suppress the target organs or cells.
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HYPOTHESIS AND SPECIFIC AIMS

The overall hypothesis is that arsenic at environmentally relevant concentrations
disrupts the development of thymocytes through both genotoxic and non-genotoxic
mechanisms, and interacts with other environmental agents such as PAHs to enhance the
genotoxic effects.

Specific Aims
Specific Aim 1: To examine both the genotoxic and non-genotoxic effects of
environmentally relevant concentrations of arsenic (As) in mouse thymus cells, and
compare the arsenic induced genotoxicity in three important immune organs (bone
marrow, spleen and thymus).The hypothesis to be tested is that arsenic can induce both
genotoxicity and non-genotoxicity in mouse thymus cells. The study will not only
examine the potential toxic effects of arsnic at very low concentrations, but also provide
the mechanistic insights to the thymic toxicity and immunosuppression previously
observed by other groups in population studies. The As+3 induced genotoxicity in vivo
will be examined in bone marrow, spleen and thymus. Aim 1 is separated into the
genotoxic effects (Chapter 2), the non-genotoxic effects (Chapter 3), and the comparison
of the sensitivities to As+3 of the three immune organs (Chapter 4).

Specific Aim 2: To investigate the interaction between polycyclic aromatic hydrocarbons
(PAHs) and the trivalent inorganic form of arsenic, As+3, on genotoxic pathways in
primary mouse thymocytes. The hypothesis to be tested is that certain PAHs such as BaP
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can increase DNA damage in thymus cells, and As+3 at low concentrations inhibits the
DNA repair system by suppressing PARP activity without causing a significant increase
in oxidative stress, leading to a synergistic genotoxic effect that increase the DNA
damage induced by the PAHs or As+3 alone. The study (Chapter 5) will reveal the
possible synergistic genotoxic effects induced by the combined exposures of PAHs and
arsenic and identify the potential mechanisms.

Specific Aim 3: To determine the differences in sensitivity of mouse thymocyte subsets
to inorganic arsenic and associated mechanisms. Based on our observations from Specific
Aim 1 and Aim 2, the hypothesis to be tested is that the differences in sensitivity of the
DN cells and DP cells are due to their differences in transporter expressions and high
intracellular As+3 accumulations. The study (Chapter 6) will not only provide a
mechanistic view of differential sensitivity to arsenic in the same type of cells at different
developmental stages, but also answer a fundamental question in As+3 toxicity studies:
when exposed to As+3, how much As+3 really gets inside the cells?

Aim 1 will provide the possible mechanisms of how arsenic induces the
suppression of early developing T cells in thymus, which may potentially cause the
suppression of immune function. Since the combination exposures are common in real
environmental conditions, the mechanism of the interactive effects between PAH and
arsenic revealed in Aim 2 will be a good example and reference for environmental
exposure studies and safety assessment. Results from Aim 3 will provide a potential
mechanism that why certain malignant cells are resistant to arsenic induced toxicity.
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Figure 1.8. The premise for current study.
Hypothesis: arsenic induces both genotoxicity and non-genotoxicity in thymus cells. BaP
and its metabolites can interact with arsenic to exert the genotoxicity. DN and DP cells
have differential sensitivity to arsenic induced genotoxicity regulated by the
transportation of arsenic.
?1. Do low doses of arsenic cause genotoxicity and non-genotoxicity in thymus cells?
?2. Could BaP and its metabolites interact with arsenic in genotoxicity?
?3. Are there any differences in sensitivity of DN and DP cells to arsenic? Mechanisms?
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Animal and cell models; Rationale for arsenic concentrations
Based on the previous studies in our lab, male C57BL/6J mice were purchased
from Jackson Laboratory at 8 weeks old. After 1 week of accommodation to our animal
facility, mice were exposed to 0 to 500 ppb As+3 for 30 d via drinking water to mimic the
long-term environmental arsenic exposures. Epidemiology studies indicated that people
can environmentally expose to arsenic up to 700 ppb concentrations (Chowdhury et al.,
2000). The dose range in the study was lower than many other arsenic in vivo studies.
Both isolated primary mouse thymus cells and a DN mouse thymic T cell line,
D1, were used in the in vitro studies. D1 cells were generated from the thymus cells of
male p53 knockout mice (Kim et al., 2003). The cells are highly IL-7 dependent and
negative for both CD4 and CD8 cell surface markers. Most of the genotoxicity studies
were performed on primary thymus cells first. The D1 cells were used in gentoxicity
studies after experimental confirmation that arsenic induced genotoxic effects in D1 cells
were comparable to primary thymus cells. D1 cells were also used in IL-7 signaling
studies as DN thymus cells, since primary DN cells are a small population among thymus
cells (~5%). Therefore, the use of the D1 cell line in our study helped to save the time
and cost, and reduced the use of animals. For the in vitro arsenic treatments,
concentrations were kept within nanomolar range (10 ppb ≈ 130 nM).
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ABSTRACT

Inhibition of DNA repair and oxidative stress are two common mechanisms
associated with arsenic-induced genotoxicity. The purpose of this study was to examine
mechanisms of genotoxicity induced by environmentally-relevant doses of arsenite (As+3)
in mouse thymus cells. An increase in DNA damage and a decrease in PARP activity
were seen in vitro following exposure to 50 nM As+3 in primary mouse thymus cells and
a murine thymus pre-T cell line, D1. 3,4-Dihydro-5[4-(1-piperindinyl) butoxyl]-1(2H)isoquinoline (DPQ), a well-characterized PARP inhibitor, also produced DNA damage in
D1 cells, confirming the correlation between PARP inhibition and DNA damage
increase. As+3 at 500 nM induced double strand breaks (DSBs) in DNA and oxidative
stress at 4 h in D1 cells, which was reversed at 18 h. No apoptosis or decrease of viability
was observed in these exposures. 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl
(TEMPOL), a widely-used antioxidant, was utilized to confirm that oxidative stress is
partially responsible for the increase of strand breaks in 500 nM As+3 exposure at 4 h.
Expression of As+3 exporters, Mdr1 and Mrp1, were found to be induced by 500 nM As+3
in D1 cells, suggesting a possible mechanism for reversal of oxidative stress and DSBs at
the 18h timepoint. Finally, we showed that DNA damage and PARP inhibition by As+3
were reversed by zinc (Zn+2) at approximate equimolar doses. Collectively, these results
demonstrate that As+3 at doses within the nanomolar range induce genotoxicity by
inhibiting PARP, and produces oxidative stress at higher concentrations, which can be
reversed by a Zn+2 treatment.
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INTRODUCTION

Two primary forms of inorganic arsenic (As), trivalent arsenite (As+3) and
pentavalent arsenate (As+5), are found in air, food and drinking water in many countries
around the world. As+3 exposure is associated with diseases such as skin lesions, diabetes,
cardiovascular diseases, and different types of cancers (Argos et al., 2010; SchuhmacherWolz et al., 2009; Vahter et al., 2008). Although growing evidence indicates that As+3
affects the immune system in multiple aspects, the exact mechanisms are still poorly
understood (Dangleben et al., 2013). Oxidative stress due to formation of reactive oxygen
species (ROS) and inhibition of DNA repair are the two most common mechanisms
proposed for As-induced genotoxicity (Faita et al., 2013). An increase in ROS has been
observed in multiple models after As+3 treatment such as keratinocytes, lymphoid cells,
and many types of cancer cells (Cooper et al., 2009; Li et al., 2001; Zhang et al., 2011).
ROS production leads to multiple effects in different types of cells, including apoptosis or
necrosis, cell cycle arrest, generation of both single (SSB) and double strand breaks
(DSB), and gene mutation (Bauer et al., 2011; Shi et al., 2004; Wiseman et al., 1996).
Poly(ADP-ribose) polymerase (PARP), the ‘nick sensor’ in base excision repair
(BER) for SSBs and direct participant in the repair of oxidative DNA damage, is directly
inhibited by As+3 (Qin et al., 2012; Zhou et al., 2011). PARP is a protein with a DNA
binding domain containing two C3H1 zinc (Zn) finger motifs, and replacement of Zn
with As+3 is believed to be the mechanism that disrupts the coordination sphere in the Zn
finger environment, impairing function of the protein (Zhou et al., 2014). There is also
evidence that DNA damage caused by spontaneous base loss or genotoxic agents are
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repaired by BER (Zharkov, 2008), and inhibition of PARP may leave damaged DNA
unrepaired, leading to the formation of DSBs in a replication-dependent manner
(Carrozza et al., 2009). DSBs are repaired through non-homologous end joining,
microhomology-mediated end joining, or homologous recombination, which are
detrimental to cells and may lead to mutation or apoptosis (Kaina, 2003; Lieber, 2010).
Previous studies in our laboratory reported that in vivo drinking water exposure to
As+3 suppresses mouse bone marrow and spleen cell function (Ezeh et al., 2014).
Exposure of spleen cells in vitro suppressed T cell dependent humoral immunity at
concentrations as low as 500 nM (Li et al., 2010). Studies in human peripheral blood
mononuclear cells (HPBMC) showed a dose-dependent suppression of T cell
proliferation at extremely low concentrations of As+3 (0.1-10 nM) in some individuals
(Burchiel et al., 2014). These studies demonstrate that human and mouse lymphocytes are
extremely sensitive to low concentrations of As+3 that likely reflect environmental
exposures. Because our previous studies showed the bone marrow cells are sensitive to
low doses of As+3 exposure (Ezeh et al., 2014), the purpose of the present studies was to
examine whether thymus cells are also sensitive to As+3 and to determine potential
mechanisms of genotoxicity.
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METHODS

Isolation of primary mouse thymus cells
C57BL/6J male mice were purchased at 8 to 10 weeks of age from Jackson
Laboratory (Bar Harbor, ME). All animal experiments were performed following the
protocols approved by the Institutional Animal Use and Care Committee at the University
of New Mexico Health Sciences Center. Mouse thymuses were harvested and transferred
to the laboratory in Hanks Balance Salt Solution (HBSS, Lonza, Walersville, MD). Cells
from each thymus were prepared as single cell suspensions by placing the organ between
the frosted ends of two microscope slides (Fisher Scientific, Pittsburgh, PA) and
squeezed into a dish containing 5 mL of the mouse medium [RPMI-1640 (SigmaAldrich, St.Louis, MO) with 10% FBS (HyClone Laboratories, Logan, UT), 2 mM Lglutamine (Life Technologies, Grand Island, NY), 100 mg/ml streptomycin, 100 units/ml
penicillin (Life Technologies)]. Cells from 3 mice were pooled, centrifuged at 200 xg for
10 min and resuspended in the mouse medium. Cell viability was determined by acridine
orange/propidium iodide (AO/PI) staining and counting using the Nexcelom Cellometer
2000.
Culture and treatment of D1 cell
The D1 cell line is a CD3+CD4-CD8-, IL-7 dependent pre-T cell line established
from p53−/− mouse thymocytes (Kim et al., 2003). It was a generous gift from Dr. Scott
K. Durum (Center for Cancer Research, National Institute of Health, Frederick, MD). It is
one of the few mouse pre-T cell lines that can be used to examine effects of xenobiotics
on early thymic T cells. Cells were maintained in RPMI 1640 with 10% FBS (Atlanta
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Biologicals, Flowery Branch, GA), 2 mM L-glutamine, 100 mg/ml streptomycin, 100
units/ml penicillin, and 50 ng/ml recombinant mouse IL-7 (PeproTech, Rocky Hill, NJ).
Cells were seeded at 5x104 cells/ml and subcultured every 3-4 days. Cell numbers and
viabilities were determined by Trypan Blue and Nexcelom Cellometer 2000. For different
experiments, cells were treated with sodium arsenite (Sigma-Aldrich), 4-hydroxy-2,2,6,6tetramethylpiperidin-1-oxyl (TEMPOL) (Sigma-Aldrich), or 3,4-Dihydro-5[4-(1piperindinyl) butoxyl]-1(2H)-isoquinoline (DPQ) (Santa Cruz Biotechnology, Dallas,
TX).
The Single Cell Gel Electrophoresis assay (Comet assay)
All reagents for the Comet assay were purchased from Trevigen (Gaithersburg,
MD) unless otherwise noted. After treatments, cells were washed with Dulbecco's
phosphate-buffered saline without Ca+2 and Mg+2 (DPBS-, Mediatech, Manassas, VA)
and immobilized in a bed of low melting point agarose on a Trevigen CometSlide™.
Cells were lysed with Lysis Solution + 10% DMSO (Sigma-Aldrich), and
electrophoresed in basic buffer (pH>13) with 21 volts in 30 minutes. Slides were dried,
stained with Sybr Green and imaged by epifluorescence microscopy. From the image, 50
cells from each well on each of the slides were scored using CometScore (TriTek Corp.,
Sumerduck, VA). DNA damage was reported by percentage of DNA in tail (Collins AR,
2004).
PARP activity assay
A PARP/Apoptosis Kit from Trevigen was used to detect PARP activity in As+3
treated cells. Experiments were performed following the protocol described by Sun et al.,
2012. After harvest, cells were lysed with Cell Extraction Buffer and total protein
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concentrations in cell extracts were determined by BCA Protein Assay (Thermo
Scientific, Rockford, IL). 200 ng of total proteins was combined with activated DNA and
nicotinamide adenine dinucleotide (NAD) and loaded into a histone-coated strip well to
form PAR and be fixed on the well bottom. After 30 min incubation at room temperature
(RT), anti-PAR monoclonal antibody was added to the well to bind to PAR followed by
an HRP conjugated secondary antibody. TACS- Sapphire™ was used to generate the
chemiluminescence signal, then stopped by adding 0.2 M HCl. The signal was detected
using SpectraMax® 340PC microplate reader (Molecular Devices).
Phospho-H2AX (Gamma H2AX) Flow Cytometry Assays
Alexa Fluor® 647 mouse anti-H2AX (pS139) was purchased from BD
Biosciences (San Jose, CA). Antibody was diluted with DPBS- 1:9 before use. Harvested
cells were washed with cold DPBS-. 3.7% freshly prepared formaldehyde was added to
fix the cells for 10 min at RT. After another wash, cells were permeablized with -20°C
90% methanol at RT for 5 min. Cells were washed again and then stained with 50 µl per
sample of diluted antibody at RT for 1 h in dark. Stained cells were washed rinsed and
resuspended with DPBS- and analyzed on BD AccuriTM C6 flow cytometer.
Gamma H2AX Western Blot
Total protein lysate (10 μg) was resolved on a 10% Criterion® Tris-HCl gels
(Bio-Rad, Hercules, CA) and transferred onto a nitrocellulose membrane (Bio-Rad).
After blocking for 1h at RT in TBST [50 mM Tris + 150 mM NaCl + 0.05% Tween 20]
containing 5% blotting-grade blocker (Bio-Rad), the membrane was then incubated with
a phospho-H2AX (Ser139) antibody (Rabbit, 1:1000, Cell Signaling Technology,
Danvers, MA) overnight at 4 °C. After washing with TBST, the membrane was incubated
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for 1 h at RT with anti-rabbit IgG, HRP-linked antibody (1:1000, Cell Signaling
Technology). Following incubation, the membrane was washed and the resulting signal
was detected with the SuperSignal West Femto Chemiluminescent Substrate (Thermo
Scientific).
Dihydroethidium (DHE) staining
DHE was purchased from Life Technologies, resuspended with 158 µl DMSO
and diluted with 20 ml DPBS- to a final concentration of 5 µM. D1 cells were treated
with 0, 50 or 500 nM As+3 for 2, 4 or 18 h. After treatment, cells were washed twice with
cold wash buffer [DPBS- +1% FBS +0.9% sodium azide (Sigma-Aldrich)]. Each sample
was stained using 5 µM DHE in DPBS- with 37 °C incubation for 30 min. Cells were
then washed with cold wash buffer, resuspended in 500 µl DPBS- and analyzed on BD
AccuriTM C6 flow cytometer.
Annexin V/Propidium Iodide staining
FITC Annexin V Apoptosis Detection Kit II (Cat. No. 556570) was purchased
from BD Biosciences. D1 cells exposed to 50 and 500 nM As+3 in vitro were washed
twice with DPBS-. 1 x 105 cells were resuspended in 100 μl 1X Annexin V Binding
Buffer, 5 μl of FITC Annexin V and 5 µl of Propidium Iodide Staining Solution were
added to each sample for 15 min at RT in dark. 400 µl of 1X Annexin V Binding Buffer
was added and the samples were analyzed by BD AccuriTM C6 flow cytometer. D1 cells
treated with 10 μM Etoposide for 4 h were used as positive control. D1 cells blocked with
5 μg of purified recombinant Annexin V and unstained D1 cells were used for gating.
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RNA isolation and HO-1 qPCR
RNeasy Mini Kit ™ and QIAshredder™ (Qiagen, Valencia, CA) were used
according to manufacturer’s instructions to isolate RNA from As+3 treated D1 cells.
RNA was then quantified on an Agilent Nanodrop spectrophotometer. All samples were
stored at -20 °C until assayed. For each reverse transcriptase (RT) reaction, 60 µl
containing a minimum of 1080 ng RNA was run on PTC-200 Thermal Cycler (MJ
Research, Reno, NV) using the High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Foster City, CA) under the following conditions: 25 °C for 10 min, 37 °C for
2 h. Samples were then diluted to ~9 ng/ µl with RNase, DNase free water and stored at 20 °C. Real time PCR (qPCR) reactions utilizing Mm_Hmox1_1_SG QuantiTect®
Primer Assay and QuantiTect® SYBR® Green PCR Kit (Qiagen) were carried out on
Applied Biosystem’s 7900HT system in a 384 well plate at 10 µl per reaction and 1 µL
cDNA (~9 ng total RNA) was added to each well. qPCR thermal cycling parameters used
were polymerase activation 15 min 95 °C, denature 15 s at 94 °C, anneal 30 s at 55 °C,
and extend 30 s at 72 °C (denature-anneal-extend for 40 cycles). Comparative CT (first
amplification cycle exceeding threshold) method was applied for relative quantification,
using GADPH gene as the endogenous reference. To calculate the comparative CT,
briefly, the difference in CT (ΔCT) values between target and endogenous control were
determined. Then the fold differences in gene expression (ΔΔCT) and the ΔCT of the
control was subtracted from the ΔCT of the target (ΔCT target-ΔCT calibrator). This
calculation is described in detail in the manual from Applied Biosystems.
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As+3 Exporter Assays
RNA samples of 500 nM As+3 treated D1 cells harvested at 2, 4 and 18 h were
prepared as above. The concentration of total RNA was quantified by UV
spectrophotometry at 260/280 nm using a Nanodrop spectrophotometer 2000 (Thermo
Scientific). Complementary DNA was generated from 1 g RNA using the High
Capacity cDNA Reverse Transcription Kit (Life Technologies). The mRNA expression
of mouse transporters was quantified by qPCR using SYBR® Green to detect amplified
products in the Applied Biosystem’s 7900HT PCR system. Primers used in the analysis
are listed below. Ct values were converted to ΔΔCt values by comparing to a reference
gene, ribosomal protein 13a (Rpl13a). For Mrp1 and Mdr1 protein expressions, Cell
lysates (10-13 µg protein/well) were separated by SDS-PAGE electrophoresis and
transferred to a nitrocellulose membrane at 4C overnight. After blocking with 5% nonfat
dry milk in 0.5% phosphate buffered saline with 0.5% of Tween 20 (PBS/T), membranes
were incubated with primary antibodies against Mdr1 (C219) (Novus Biologicals,
Littleton, CO) and Mrp1 (Alexis, Farmingdale, NY) followed by incubations with
species-appropriate secondary antibodies for 1 to 2 h. The SuperSignal West Dura
Chemiluminescent Substrate (Thermo Scientific) was applied to the membranes prior to
detection of luminescence using a FluorChem Imager (Alpha Innotech, San Leandro,
CA). Target protein band intensities were semi-quantified and normalized to β-actin
levels (ab8227 antibody, Abcam).
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Table 2.1 Primers used for As+3 exporter qPCR analysis

Transporters
Mrp1

Forward (5’-3’)

Reverse (5’-3’)

GCTGTGGTGGGCGCTGTCTA

CCCAGGCTCAGCCACAGG
AA

Mrp2

AGCAGGTGTTCGTTGTGTGT

AGCCAAGTGCATAGGTAG
AGAAT

Mdr1a

TGCCCCACCAATTTGACACCCT

ATCCAGTGCGGCCTGAAC
CA

Mdr1b

GTGTTAAAGGGGCGATGGGCG

AGGCTTGGCCAGACAACA
GCTT

Statistics
Data were analyzed using Excel 2010 and Sigma Plot 12.5 software. One-way
analysis of variance (ANOVA) and Dunnett’s t-test were used to determine differences
between control and treatment groups. For in vivo As+3 treatment, both treatment groups
consisted of five animals and each animal was analyzed in triplicates. For the in vitro
experiments, three replicates were performed and analyzed for each single dose.
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RESULTS

As+3 exposure increased DNA damage and inhibited PARP in primary mouse
thymus cells in vitro
Primary thymus cells from C57BL/6J male mice were isolated and treated with 5
and 50 nM As+3 and harvested at 4 and 18 h. An increase in DNA damage and a decrease
in PARP activity were seen in cells treated with 50 nM As+3 at both time points (Fig.
2.1A and 2.1B), indicating the genotoxic effects of As+3 on mouse thymus cells in vitro.
These results not only demonstrate that environmentally-relevant doses of As+3 induce
genotoxic events in mouse thymus cells, but also suggest that inhibition of PARP activity
by As+3 is involved in, and may be the mechanism responsible for the increase in DNA
damage.
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Figure 2.1. Genotoxicity in primary mouse thymus cells exposed to As+3 in vitro. Naïve
primary thymus cells from C57BL/6J male mice were exposed to 5 and 50 nM for As+3
for 4 and 18 h in vitro. A, DNA damage was measured by percentage of DNA in tail
using the alkaline Comet assay. B, PARP activity was measured with Trevigen ELISA
kits represented by absorbance at 450 nm. *Significantly different compared to control
(p<0.05, n=5). Results are Means ± SD.
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Increased DNA damage after As+3 exposure is directly related to PARP inhibition in
pre-T cells
We utilized an IL-7 dependent, CD3+CD4-CD8- pre-T cell line, D1, to further
examine the genotoxicity induced by As+3 in mouse thymus cells. D1 cells were treated
with As+3 at 5, 50 and 500 nM in vitro for 4 and 18 h. A significant increase of DNA
damage was observed in 50 and 500 nM As+3 treated cells for 4 and 18 h (Fig. 2.2A). A
significant decrease in PARP activity was also seen at 4 and 18 h in 50 and 500 nM As+3
treated cells (Fig. 2.2B). Therefore, As+3 induced similar genotoxic events in D1 cells as
compared to primary thymus cells.
To determine if DNA damage increased by As+3 is related to PARP inhibition, we
treated the D1 cells with a potent PARP inhibitor, DPQ. A significant increase in DNA
damage was observed with 1 µM DPQ at 4 h (Fig. 2.2C) and 0.1µM DPQ at 18 h (Fig.
2.2D), indicating that the DNA damage observed with As+3 treatments was likely to be
the result of PARP inhibition, which leaves damaged DNA unrepaired. However, because
the DNA damage in the DPQ treatments seemed to have a limitation at around 15% of
DNA in tail, while As+3 induced DNA damage easily exceeded this amount, it was
thought that As+3 may act through additional mechanisms than inhibiting PARP alone,
such as oxidative stress at higher concentrations (Fig. 2.2C and 2.2D).
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Figure 2.2. Genotoxicity in D1 cells exposed to As+3 or PARP inhibitor (DPQ). D1 cells
were treated with 5, 50 or 500 nM As+3 for 4 and 18 h. A, DNA damage was measured by
percentage of DNA in tail using alkaline Comet assay. B, PARP activities were measured
with Trevigen ELISA kit represented by absorbance at 450 nm. C and D, DNA damage
were measured by alkaline Comet assay in D1 cells treated with 5, 50 and 500 nM As+3
and 0.1, 1 and 10 µM PARP inhibitor, DPQ for 4 h (C) and 18 h (D). *Significantly
different compared to control (p<0.05). Results are Means ± SD.
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As+3 exposure at 50 and 500 nM induces double strand breaks in D1 cells at early
time points
The DNA damage observed in alkaline Comet assay represents the total strand
breaks including both single and double strand breaks (Collins, 2004). We have already
shown that 500 nM As+3 caused significant genotoxicity which exceeded the effects of
PARP inhibitor, so it was hypothesized that besides the inhibition of DNA repair,
oxidative stress may also be involved higher levels of As+3 exposure (e.g., 500 nM).
When DSBs occur, H2AX is phosphorylated on serine 139, also known as gamma H2AX
and is often used as a marker for DSBs (Mah et al., 2010). Therefore, we treated D1 cells
with 0, 50 and 500 nM of As+3 and harvested cells at 2, 4 and 18 h. Phospho-H2AX
antibody was used to stain the cells in order to measure the phospho-H2AX level using
flow cytometry. An increase in phospho-H2AX mean channel fluorescence was observed
in cells exposed to 500 nM As+3 at both 2 and 4 h time points, but not at 18 h (Fig. 2.3A),
indicating that double strand breaks were generated by As+3 treatment in D1 cells in early
stages at high concentration (500 nM). We also confirmed the observation by Western
Blot (Fig. 2.3B).

Time-dependent oxidative stress in D1 cells exposed to As+3
Oxidative stress is commonly associated with the induction of DSBs. We used
DHE staining to examine the superoxide level and Heme Oxygenase-1 (HO-1)
expression by qPCR to see if oxidative stress is involved in the genotoxicity induced by
As+3. As determined by DHE fluorescence, a significant increase in superoxide level was
observed at 500 nM following 2-4 h of treatment (Fig. 2.3C), but not at the 18 h time
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point, indicating that it is an early stage event occurring at high exposure levels. HO-1 is
known to be induced by oxidative stress and considered to be protective to cells (Vile et
al., 1994). An approximate 8-fold increase in HO-1 expression was observed at 2 h and a
more significant 20-fold increase was seen at 4 h in 500 nM As+3 treatment, but dropped
to control levels at 18 h (Fig. 2.3D). These results suggested a time-dependent oxidative
stress and DSBs occurrence in D1 cells treated with a high dose of As+3 (500 nM).
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Figure 2.3. Phospho-H2AX (γ-H2AX) expression and oxidative stress in D1 cells
exposed to As+3. D1 cells were treated with 50 or 500 nM As+3. Phospho-H2AX
expression levels were measured by flow cytometry (A), represented by Mean Channel
Fluorescence or Western Blot (B). C, Mean Channel Fluorescence of DHE. D, HO-1
RNA levels were measured by qPCR on cDNA samples from As+3 treated D1 cells.
*Significantly different compared to control (p<0.05). Results are Means ± SD.
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Exposure to As+3 did not induce apoptosis in D1 cells
Since DNA strand breaks and oxidative stress apoptosis may lead to cell death
and the loss of PARP activity through caspase catalyzed PARP cleavage (Los et al.,
2002), Annexin V and Propidium Iodide (PI) were used to check if D1 cells were
apoptotic after As+3 exposure. No significant changes were found in both viability (% of
Annexin V-, PI- cells, Fig. 2.4A and 2.4B) and % of apoptotic cells (% of Annexin V+
cells, Fig. 2.4A and 2.4C) in D1 cells exposed to 50 and 500 nM As+3 at 2, 4 and 18 h.
The results excluded the possibility that decrease of PARP activity observed in low
concentrations of As+3 exposure was induced by increase of apoptosis.
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Figure 2.4. Annexin V and Propidium Iodide Staining in D1 cells exposed to As+3. D1
cells were treated with 50 or 500 nM As+3 for 2, 4 and 18 h, or 10 µM Etoposide as
positive control. A. Flow cytometry results showing D1 cells which are Annexin V-PI(LL), Annexin V+PI- (LR), Annexin V-PI+ (UL), or Annexin V+PI+ (UR). B, viability
(% of Annexin V-PI- cells). C. % of apoptotic cells (% of Annexin V+ cells).

46

Oxidative stress was partially responsible for the increase of DNA damage in 500
nM As+3 exposure at 4 h
In order to confirm that oxidative stress and superoxide production is directly
related to the increase of DNA damage at 500 nM As+3, we utilized a superoxide
scavenger, TEMPOL, to perform co-exposure studies with As+3 for 4 h, at which time
point oxidative stress was observed (Fig. 2.3C and 2.3D). A significant decrease of
superoxide levels was observed in 500 nM As+3 and 100 µM TEMPOL co-exposure
comparing to 500 nM As+3 only (Fig. 2.5A), indicating that TEMPOL inhibited the
production of superoxide induced by 500 nM As+3. At the same time, DNA damage was
also decreased by a small amount (~2%) in As+3 and TEMPOL co-exposure (Fig. 2.5B),
suggesting that oxidative stress and superoxide production was directly related to the
DNA damage in 500 nM As+3 exposure at 4 h, but that oxidative stress and DSBs
represent only a small percentage of total DNA strand breaks. PARP activity was not
affected by adding TEMPOL in As+3 exposure (Fig. 2.5C). Collectively, these results
indicate that oxidative stress contributes to DNA damage in D1 cells exposed to 500 nM
As+3 at 4 h.
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Figure 2.5.Superoxide level and genotoxicity in D1 cells exposed to As+3 and TEMPOL
for 4 h. D1 cells were exposed with 50 or 500 nM As+3, with or without co-exposure to
100 µM TEMPOL. A. Mean Channel Fluorescence of DHE represents superoxide level.
B. DNA damage was measured by percentage of DNA in tail using alkaline Comet assay.
C. PARP activity was measured with Trevigen ELISA kits represented by absorbance at
450 nm. *Significantly different compared to control (p<0.05). # Significantly different
compared to 500 nM As+3 (p<0.05).Results are Means ± SD.
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Induction of As+3 exporters by 500 nM As+3
Because 500 nM As+3 induced DSBs and oxidative stress in D1 cells at early time
points (2 and 4 h) but not at 18 h, we examined potential mechanisms responsible for this
reversal . One possible mechanism is that 500 nM As+3 induces the expression of As+3
exporters such as the multidrug resistance-associated proteins 1 and 2 (Mrp1, Mrp2) or
the multidrug resistance protein 1 (Mdr1) (Liu et al., 2001; Liu et al., 2002).
Enhancement of efflux transporter expression could reduce intracellular levels of As+3
thereby reducing the toxic effects. Therefore, we examined the mRNA expression of
Mrp1, Mrp2, Mdr1a and Mdr1b in D1 cells treated with 500 nM As+3 at 2, 4 and 18 h. An
increase of Mrp2 (and to some extent Mrp1) expression was observed in D1 cells treated
with 500 nM As+3 at 18 h (Fig. 2.6B). Interestingly, Mdr1a and Mdr1b were up-regulated
at 2 h and down-regulated by 18 h (Fig. 2.6C and 2.6D), which was different from the
expression of Mrp1 and 2 (Fig. 2.6A and 2.6B). Western Blots confirmed that the protein
level of Mrp1 was up-regulated at 18 h (Fig. 2.7A and 2.7B). However, Mdr1 protein
levels were not decreased at 18 h, which was different from the mRNA expression (Fig.
2.7C and 2.7D). Mrp2 protein was not detectable in D1 cell lysates. Collectively, these
results suggest that the induction of As+3 exporters may play a role in regulating As+3
induced genotoxicity at high concentrations (500 nM).
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Figure 2.6. mRNA expression of As+3 exporters in D1 cells treated with 500 nM As+3.
D1 cells were treated 500 nM As+3, expression of Mrp1, Mrp2, Mdr1a and Mdr1b at 2, 4
and 18 h was examined by RT-PCR. A, Mrp1. B, Mrp2. C, Mdr1a. D, Mdr1b.
*Significantly different compared to control (p<0.05). Results are Means ± SD.
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Figure 2.7. Protein levels of Mrp1 and Mdr1 in D1 cells treated with 500 nM As+3. D1
cells were treated 500 nM As+3, expression of Mrp1and Mdr1 at 2, 4 and 18 h was
examined by Western Blot. A, Mrp1 Western Blot. B, Mrp1 band intensity normalized to
Actin. C, Mdr1 Western Blot. D, Mdr1 band intensity normalized to Actin. *Significantly
different compared to control (p<0.05). Results are Means ± SD.
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1 µM Zn+2 reversed the DNA damage and PARP inhibition induced by As+3
Since PARP is a zinc finger protein and Zn+2 was found to reverse the PARP
inhibition induced by As+3 in HaCat cells (Sun et al., 2012), we wanted to know if Zn+2
would reverse the DNA damage induced by As+3 in mouse pre-T cells. D1 cells were
treated with 50 or 500 nM As+3, 1 µM Zn+2 and the combinations as Zn+2 + As+3. 1 µM
Zn+2 reversed the DNA damage induced by 50 and 500 nM As+3 at both 4 and 18 h (Fig.
2.8A). In addition, PARP inhibition induced by 50 and 500 nM As+3 at both 4 and 18 h
was also reversed by 1 µM Zn+2 (Fig. 2.8B). Therefore, the genotoxic effects induced by
As+3 in thymus cells can be reversed by Zn+2, suggesting that Zn may be involved in the
mechanism of action of As+3.
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Figure 2.8. Protective effect of Zn+2 supplement in As+3 induced DNA damage and
PARP activity in D1 cells. D1 cells were treated with 50 and 500 nM As+3, 10 µM Zn+2,
or the combinations. A, DNA damages were measured by percentage of DNA in tail
using alkaline Comet assay. B, PARP activities were measured with Trevigen ELISA kit
represented by absorbance at 450 nm. *Significantly different compared to 50nM As+3
(p<0.05), # Significantly different compared to 500 nM As+3 (p<0.05). Results are Means
± SD.
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DISCUSSION

Suppression of immune function by As has been observed in vivo and in vitro by
several groups (Burchiel, et al., 2014; Ezeh et al, 2014; Gonsebatt et al., 1994; Nadeau et
al., 2014; Vahter et al., 2008; Ahmed et al., 2014; Biswas et al., 2008; Soto-Peña et al.,
2006), and may potentially contribute to unregulated cancer cell growth. As+3 is
considered to be a co-carcinogen in keratinocytes, as it does not induce detectable DNA
damage at low concentrations without the co-existence of other carcinogens such as UV
light (Qin et al., 2012). As+3 inhibits DNA repair enzymes such as PARP and XPA (Zhou
et al., 2011), which may decrease the ability of cells to repair spontaneous endogenous
strand breaks (Swenberg et al., 2011), leading to an increase in DNA damage. Our results
showed that As+3 alone induced a significant increase in DNA damage in mouse thymus
cells (Fig. 2.1A, 2.1C and 2.2A) by inhibiting PARP. Also, thymus cells required less
As+3 to induce DNA damage than keratinocytes, indicating there is a difference between
their sensitivities to As+3. The difference may be due to the exposure relating to passive
and active transporters of As+3 (Jiang et al., 2006), the ability to metabolize As+3, or
differences in other intra/extracellular pathways affected by As+3. It is important to
further identify the mechanisms underlying these differences in sensitivity.
PARP is the initiator of BER, which has a critical role in DNA repair. Recent
studies have also revealed the relationship between PARP inhibition and
immunosuppression. PARP-1 was found to regulate TGF-β receptor expression in
immune cells, and inhibition of PARP-1 up-regulated Foxp3, a primary marker for Tregs,
and an increase in Th17 cell number (Zhang et al., 2013). In our experiment, there was a
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significant decrease in PARP activity and increased DNA damage in both primary
thymus cells and the D1 cell line treated with very low concentrations of As+3 (50 nM).
PARP inhibition induced by As+3 may not only affect T cell development in the thymus,
but may also cause immunosuppression in peripheral T cells.
PARP is also known to affect other DNA repair pathways, including nonhomologous end-joining and homologous recombination (Yelamos et al., 2011). We
found that As+3 at 500 nM induced DSBs at 4 h, which may be the result of ROS
production (Qin et al., 2008). However, these DSBs decreased at 18 h, which correlated
with the decrease in oxidative stress markers. Therefore, it is likely that the DBSs were
induced by oxidative stress. In addition, since neither oxidative stress nor DSBs were
induced by 50 nM As+3, we conclude that As+3 induces DNA damage mainly through the
inhibition of PARP at these lower concentrations leading to the increase of spontaneous
strand breaks in thymus cells, while oxidative stress only occurs in cells treated with a
higher dose (500 nM) of As+3.
Because of the transient nature of oxidative stress and DSB induced by 500 nM
treatment with As+3 in D1 cells, we examined the expression of different As+3 efflux
proteins, hypothesizing that the induction of arsenic exporters would limit exposure and
protect cells. Mrp1 and Mrp2 are well-characterized exporters of As+3 and key players in
As+3 detoxification (Maciaszczyk-Dziubinska et al., 2012). Induction of Mrp1 and Mrp2
mRNA expression only occurred at the 500 nM exposure concentration of As+3 and
correlated with the rapid protection of D1 cells from oxidative stress and DSBs (Fig 2.4A
and 2.4B). While the mRNA expression of Mdr1a and Mdr1b were differentially
induced, with Mrp1 increased at 18 hr and Mdr1a increased at 2 hr, but returning to
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control levels at 18h (Fig 2.4C and 2.4D). Western Blots also revealed that Mrp1 was upregulated at 18 h by 500 nM As+3(Fig. 2.5A and 2.5B). One major difference between
these exporters is that Mdr1 exporters do not transport glutathione (GSH) conjugates
(Maciaszczyk-Dziubinska et al., 2012), while Mrp1 and Mrp2 are GSH-dependent
(Leslie et al., 2004; Kala et al., 2000). Therefore, it is possible that the efflux of As+3 at
18 h requires the conjugation with GSH. Besides the adaptive regulation of exporters,
further studies are needed to reveal if there are changes in the expression of As+3
importers. Studies on the relationship between As+3 transporter expressions and
intracellular As+3 level may further clarify the role of these proteins in regulating As+3
toxicity by cells.
Zn+2 has been demonstrated to counteract PARP inhibition following As+3
exposure (Cooper et al., 2013; Kumar et al., 2010). In our experiment, we found that Zn+2
reversed the DNA damage and PARP inhibition at 1 µM in D1 cells. However, when we
increased Zn+2 concentration to 10 µM, Zn+2 itself induced DNA damage (data not
shown). Therefore, Zn+2 exposure can reverse the As+3 genotoxic effects at appropriate
concentrations, while excess amounts of Zn+2 are harmful to cells.
In summary, As+3 induces significant genotoxic effects in mouse thymus cells at
environmentally-relevant concentrations and within the nanomolar range in vitro. At low
concentrations (50 nM), inhibition of DNA repair caused by PARP inhibition is mainly
responsible for SSB genotoxicity in the absence of oxidative stress. At higher
concentrations (500 nM), As+3 induces transient oxidative stress and DSBs that are
limited by the induction of exporters that reduce concentrations of intracellular arsenic.
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The dose-dependent differential genotoxicity of As+3 at environmentally-relevant levels
can be reversed by Zn+2 supplement.
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ABSTRACT

Environmental arsenic exposure is a public health issue. Immunotoxicity induced
by arsenic has been reported in humans and animal models. The purpose of this study
was to evaluate mechanisms of As+3 and MMA+3 toxicity in mouse thymus cells.
Because we know that MMA+3 inhibits IL-7 signaling in mouse bone marrow pre-B cells,
we studied the influence of As+3 and MMA+3 on T cell development in the thymus at the
earliest stage of T cell development (CD4-CD8-, double negative, DN) which requires
IL-7 dependent signaling. We found in a DN thymus cell line (D1) that a low
concentration of MMA+3 (50 nM) suppressed IL-7 dependent JAK1,3 and STAT5
signaling. As+3 suppressed STAT5 and Jak3 activations at higher concentration (500
nM). Cell surface expression of the IL-7 receptor (CD127) was also suppressed by 50 nM
MMA+3, but was increased by 500 nM As+3, indicating possible differences in the
mechanisms of action of these agents. A decrease in cyclin D1 protein expression was
observed in D1 cells exposed to As+3 at 500 nM and MMA+3 starting at 50 nM,
suggesting that arsenic at these environmentally-relevant doses suppresses early T cell
development through the inhibition of IL-7 signaling pathway.
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HIGHLIGHTS



As+3 and MMA+3 suppress IL-7 signaling as measured by pSTAT5 in DN
thymocytes.



JAK1 was inhibited by MMA+3, while JAK3 was inhibited by MMA+3 and As+3.



MMA+3 decreased but As+3 increased cell surface expression of the IL-7 receptors.



MMA+3 and As+3 exposures selectively decreased the DN cell population in vitro.



In DN cells, MMA+3 (50 nM) and As+3 (500 nM) inhibited cyclin D1 expression.
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INTRODUCTION

Arsenic exposure in food and drinking water is a worldwide public health issue.
Arsenic is known to cause suppression of the immune system in multiple systems
(Ahmed et al., 2014; Biswas et al., 2008; Nadeau et al., 2014; Soto-Peña et al., 2006;
Vahter et al., 2008). However, the mechanism of arsenic induced immunosuppression is
still poorly understood. Previous studies in our laboratory found that environmentallyrelevant doses of arsenite (As+3) and its metabolite, monomethylarsonous acid (MMA+3)
suppressed T cell function and early B cell proliferation at extremely low concentrations
(Burchiel et al., 2014; Ezeh et al., 2014), indicating that immune cells are very sensitive
to As+3 and MMA+3 exposure.
Early T cells are originally produced in bone marrow and transported into the
thymus for development and selection. T cells in thymus go through double negative
(CD4-CD8-, DN), double positive (CD4+CD8+, DP) and single positive (CD4+/CD8+,
SP) stages, committing to either CD4+ T helper cells or CD8+ cytotoxic T cells
(Germain, 2002). The conversion of early pre-T DN cells to DP cells is controlled by IL7 signaling (Boudil et al., 2015). Suppression of DN T cells has been documented to have
detrimental effects on immune functions (Ohm et al., 2003; Seinen and Penninks, 1979).
IL-7 is secreted by stromal cells in bone marrow and thymus and is a critical cytokine for
the proliferation of T cells during DN stage (Namen et al., 1988). The IL-7 receptor (IL7R) is a heterodimer consisting both an α chain and a common γ chain (γc). The binding
of IL-7 to IL-7R leads to a cascade of signals of Janus Kinases (JAKs) and Signal
Transducers and Activators of Transcription (STATs), inducing the transcription of
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multiple genes such as Pim1 and Cyclin D1 (de Groot et al., 2000; Linowes et al., 2013).
STAT5 is phosphorylated by phospho-JAK1 (pJAK1) and phospho-STAT5 (pSTAT5) is
stabilized by phospho-JAK3 (pJAK3) (Haan et al., 2011). Once pSTAT5 is dimerized
and translocated into the nucleus, it binds to STAT5 response elements on genes that
control proliferation and differentiation (Nosaka et al., 1999).
Arsenic-induced alterations in cell signaling, including the inhibition of tyrosine
kinase activation or ROS production, can have potent non-genotoxic effects on cells
(Qian et al., 2003). The inhibitions on STATs and JAKs in γc receptor signaling by
arsenic were observed by different groups (Cheng et al., 2004; Hayashi et al., 2002).
However, all these existing studies were conducted with high doses of arsenic. Since
there is evidence showing that low concentrations of As+3 and MMA+3 inhibit the
proliferation of IL-7 dependent lymphoid progenitors (Ezeh et al., 2014), the present
study was focused on the effects of environmentally-relevant non-cytotoxic doses of As+3
and MMA+3 within nanomolar ranges on IL-7 signaling pathway of DN mouse thymus
cells, the early developing T cell population which affects the whole immune system.
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MATERIAL AND METHODS

Chemicals and reagents
Sodium arsenite (CAS 774-46-5, NaAsO2) was purchased from Sigma-Aldrich
(St. Louis, MO). MMA+3 was a gift from Dr. Terry Monks at Southwest Environmental
Health Science Center of the University of Arizona. Hanks Balanced Salt Solution
(HBSS) was purchased from Lonza (Walkersville, MD). Penicillin/Streptomycin 10,000
(mg/ml)/10,000 (U/ml) (Pen/Strep) and 200 mM L-Glutamine were purchased from Life
Technologies (Grand Island, NY). β-Mecaptoethanol (2-ME), Dulbecco’s phosphate
buffered saline w/o Ca+2 or Mg+2 (DPBS-), and base medium RPMI 1640 were purchased
from Sigma Aldrich. Mouse IL-7 was purchased from Peprotech (Rocky Hill, NJ). Fetal
Bovine Serum (FBS) was purchased from Atlanta Biologicals (Flowery Branch, GA.),
Alexa Fluor® 488 Rat Anti-Mouse CD127 (Cat. No. 561533), Alexa Fluor® 488 Rat
IgG2b, κ Isotype Control (Cat. No. 557726), FITC Rat Anti-Mouse CD8a (Cat. No.
553031), APC Rat Anti-Mouse CD4 (Cat. No. 553051), PE-CyTM7 Hamster Anti-Mouse
CD3e (Cat. No. 552774), purified mouse anti-JAK1 monoclonal antibody (Cat. No.
610231) and purified mouse anti-STAT5 (Cat. No. 610191) were purchased from BD
Biosciences (San Jose, CA). PE Anti-Hu/Mo pSTAT5 (Y694) (Cat. No. 12-9010-42), PE
Mouse IgG1 κ Isotype Control (Cat. No. 12-4714-42) and IC fixation buffer (Cat. No. 008222-49) were purchased from eBioscience (San Diego, CA). Cyclin D1 (DCS-6) PE
(Cat. No. sc-20044 PE) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Anti-phospho-STAT5 (Tyr694) (Cat. No. 9359), anti-phospho-JAK1 (Tyr1022/1023)
(Cat. No.3331), anti-phospho-JAK3 (Tyr980/981) (Cat No. 5031), anti-JAK3 (Cat. No.
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3775), anti-rabbit IgG –HRP secondary antibody (Cat. No. 7074) and anti-mouse IgGHRP secondary antibody (Cat. No. 7076) were purchased from Cell Signaling
Technology (Danvers, MA).
Thymus cells in vitro treatments and intracellular flow cytometry assays
Thymus were harvested from three C57BL/6J male mice purchased at 8 weeks of
age from Jackson Laboratory (Bar Harbor, ME), cells were isolated and pooled. Mice
were handled in accordance with protocols approved by the Institutional Animal Use and
Care Committee at the University of New Mexico Health Sciences Center in our
AAALAC-approved animal facility. One million cells were treated with different doses
of As+3 or MMA+3 in the medium consisting of RPMI-1640, 10% FBS, 1% Pen/Strep,
and 2mM L-Glutamine at 37 oC for 18 h. For pSTAT5 intracellular staining, cells were
washed and resuspended in 100 µl of DPBS- and incubated with 5 ul cocktail consisting
of 0.5 µg of CD8, CD4 and CD3 antibodies or DPBS- (unstained) for 30 min at RT in
dark and fixed by adding 100 µl of IC fixation buffer and incubated for 30 min at RT in
dark. Following incubation, cells were washed twice with DPBS- and then incubated in
100 µl of 90% -20 oC methanol for 30 min 4 oC in dark. Washed cells were resuspended
in 100 µl of DPBS- and stained with 5 µl of intracellular staining antibody (pSTAT5,
cyclin D1) or isotype control and incubated for 30 min at RT in dark. Cells were washed
twice with DPBS- before being analyzed on an AccuriC6 Flow Analyzer (BD
Biosciences).
D1 cells pSTAT5 and pJAKs Western Blot assays
The D1 cell line was a gift from Dr. Scott K. Durum (Center for Cancer Research,
National Institute of Health, Frederick, MD). It is a CD3+CD4-CD8-, IL-7 dependent
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pre-T cell line established from p53−/− mouse thymocytes (Kim et al., 2003). Cells were
maintained in RPMI 1640 with 2 mM L-glutamine, 1% Pen/Strep, 55 µM 2-ME and 50
ng/mL IL-7. Cells were arrested in G1 phase by 18 h of IL-7 deprivation and treated with
As+3 or MMA+3 at the same time. 50 ng/mL of IL-7 was added to induce IL-7 signaling
for 30 min before harvesting. Cell lysates (20 μg protein/well) were separated by SDSPAGE electrophoresis and transferred onto nitrocellulose membranes for 15 min using
semi-dry transferring system (Bio-Rad, Hercules, CA). Membranes were blocked with
5% Blotting Grade Blocker (Bio-Rad) in TBST (50 mM Tris, 150 mM NaCl and 0.05%
Tween 20), and incubated with antibodies for pSTAT5, pJAK1 or pJAK3, followed by
HRP conjugated antibodies. The membranes were stripped with pH 2.2 glycine stripping
buffer (15 g glycine, 1 g SDS and 10 ml Tween 20 in a total of 1 L) and probed for total
STAT5, JAK1 and JAK3. Signals were detected using SuperSignal West Femto
Chemiluminescent Substrate (Thermo Scientific, Rockford, IL) and FluorChem™ M
System (ProteinSimple, San Jose, CA).
D1 cells CD127 staining
After treatments with As+3 or MMA+3, D1 cells were washed, resuspended in 100
µl DPBS- and stained with 0.5 µg of anti-CD127 or IgG2b κ Isotype Control for 30 min
at RT in the dark. Cells were washed twice with DPBS- before analyzed on an AccuriC6
Flow Analyzer
Statistics and Data Analysis
All data were analyzed with Excel 2010 or SigmaPlot version 12.5, one way
analyses of variance (ANOVA) and Dunnetts t-test were used to determine the
differences between control and treatment groups. For flow cytometry experiments, each
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single dose was done in triplicate. For Western Blot experiments, three independent
experiments were performed for each assay. Image J (1.48v) software (NIH, downloaded
from website: http://rsb.info.nih.gov/ij/) was used to obtain band intensities for treatments
and control samples.
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RESULTS

As+3 and MMA+3 suppressed STAT5 phosphorylation in mouse DN T cells in vitro
Mouse thymus cells were isolated and exposed to 5, 50 and 500 nM As+3 and
MMA+3 in vitro for 18 h. The DN T cell population was defined as negative for both CD4
and CD8 markers in CD3+ thymocytes (Fig. 3.1A) using flow cytometry. STAT5
phosphorylation was measured by intracellular staining and found to be inhibited by As+3
at 500 nM and MMA+3 from 50 nM (Fig. 3.2B), indicating a suppression of the IL-7
signaling pathway at these doses in vitro.
A DN, IL-7 dependent mouse thymic cell line, D1, was utilized to confirm our
observations in the primary mouse DN T cells. STAT5 activation is IL-7 responsive in
D1 cells, and neither As+3 or MMA+3 induced STAT5 phosphorylation without IL-7 (Fig.
3.1C and 3.1D). A significant decrease in STAT5 phosphorylation was seen in 500 nM
As+3 and 50 nM MMA+3 treatments (Fig. 3.1C and 3.1D), confirming the observations in
primary mouse DN T cells.
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Figure. 3.1. Suppression of STAT5 phosphorylation in DN primary thymus T cells
exposed to As+3 and MMA+3 in vitro. Primary mouse thymus cells were treated with 5, 50
and 500 nM As+3 and MMA+3. A, DN T cell population defined by CD3, CD4 and CD8
cell surface markers and isotype control for pSTAT5 intracellular staining. B,
intracellular pSTAT5 levels were measured by multiparameter flow cytometry. In panels
1C and 1D, D1 cells were starved 18 h for IL-7 with As+3 and MMA+3 treatments.
pSTAT5 levels were measured 30 min after re-adding IL-7, three independent
experiments were performed. C, one representative pSTAT5 and STAT5 blot. D,
pSTAT5 to STAT5 band intensities from three independent experiments. *Significantly
different compared to control (p<0.05). Results are Means ± SD.
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Figure. 3.2. Suppression of JAK1 and JAK3 phosphorylation in a mouse DN cell line
(D1) exposed to As+3 and MMA+3 in vitro. D1 cells were starved 18 h for IL-7 with As+3
and MMA+3 treatments. pJAK1 and JAK3 levels were measured 30 min after re-adding
IL-7, three independent experiments were performed. A, one representative pJAK1 and
JAK1 blot is shown. B, pJAK1 to JAK1 band intensities from three independent
experiments are shown. C, one representative pJAK3 and JAK3 blot is shown. D, pJAK3
to JAK3 band intensities from three independent experiments are shown. *Significantly
different compared to control (p<0.05). Results are Means ± SD.
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As+3 and MMA+3 suppressed JAK1 and JAK3 phosphorylation in D1 cells in vitro
Since the suppression of STAT5 phosphorylation was observed in DN T cells,
phosphorylation of JAK1 and JAK3, upstream tyrosine kinases which phosphorylate
STAT5 in the IL-7 signaling pathway, was examined by Western Blot after IL-7
stimulation in D1 cells. As we can see in Fig. 3.2, the absence of IL-7 also depleted JAK1
and JAK3 phosphorylation. 50 nM MMA+3 exposure suppressed JAK1 phosphorylation
(Fig. 3.2A and 3.2B) and 500 nM As+3 or 50 nM MMA+3 exposures inhibited JAK3
phosphorylation (Fig. 3.2C and 3.2D) in IL-7 stimulated D1 cells. These results indicate
that suppression of STAT5 phosphorylation by As+3 and MMA+3 exposures may be due
to JAK1 and JAK3 inhibition.
MMA+3 suppressed IL-7R (CD127) expression on cell surface
In order to see if IL-7R expression is affected by As+3 and MMA+3 treatments, D1
cells exposed to 50 and 500 nM As+3 or 5 and 50 nM MMA+3 for 18 h in vitro were
stained with CD127 antibody. A decrease in cell surface expression of IL-7R was
observed in D1 cells exposed to 50 nM MMA+3 (Fig. 3.3). Interestingly, 500 nM As+3
increased the expression of IL-7R, indicating that As+3 and MMA+3 may have differential
mechanisms in IL-7 signaling suppression.
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Figure. 3.3. IL-7R (CD127) cell surface expression in D1 cells exposed to As+3 and
MMA+3 in vitro. D1 cells were exposed to As+3 and MMA+3 for 18 h and stained with
anti-CD127 antibody. A, isotype and staining control. B, surface IL-7R expression
measured by CD127 mean channel fluorescence.*Significantly different compared to
control (p<0.05). Results are Means ± SD.
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As+3 and MMA+3 selectively targeted DN T cells and decreased cell cycle protein
expression
Since the suppression of IL-7 signaling pathways in mouse DN T cells by As+3
and MMA+3 was confirmed, we wanted to determine whether the DN subset is selectively
affected and evaluate a potential mechanism. We performed intracellular staining for
cyclin D1, an indicator of cell cycle progression which is transcriptionally regulated by
STAT5 activation (Matsumura et al., 1999). These studies were performed in primary
mouse DN thymus cells exposed to As+3 and MMA+3 for 18 h in vitro. For MMA+3
exposures, we also applied doses between 50 nM and 500 nM to get more information on
dose response within the nanomolar range. MMA+3 significantly decreased the number of
DN cells, but had no effect on the DP cell populations (Fig 4A, 4B). We have previously
shown that these concentrations did not affect cell viability, therefore the fact that fewer
cells were being recovered suggested that MMA and As+3 might affect the entry of cells
into this compartment by blocking IL-7 dependent proliferation and differentiation. We
therefore examined cyclin D1 expression in the DN cells treated with MMA+3 (50-200
nM) and As+3 (500 nM). A statistically significant inhibition of cyclin D1 was seen at 100
nM MMA+3 and 500 nM As+3 indicating that these STAT5-depdent proteins was affected
by these treatments (Fig. 4C, D).
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Figure. 3.4. As+3 and MMA+3 selectively affected DN cells and suppressed cyclin D1
expression. A, Decrease in the percentage of CD3+ DN (CD4-, CD8-) cells recovered
from primary thymus cells treated for 18 h with MMA+3 or As+3. B, lack of effect of
MMA+3 and As+3 on the CD3+ DP (CD4+,CD8+) population of thymus cells. C, cyclin
D1 fluorescence detected by flow cytometry is shown for a specific antibody (left) and an
isotype control (right) for primary mouse thymus cells. D, cyclin D1 expression measured
by multiparameter flow cytometry in CD3+ DN primary mouse thymocytes treated with
50 and 500 nM As+3 or 50, 100 and 200 nM MMA+3 for 18 h in vitro. *Significantly
different compared to control (p<0.05). Results are Means ± SD.
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DISCUSSION

Environmental exposures to arsenic via drinking water and food are known to be
associated with vascular diseases, lung diseases, and different types of cancers (Argos et
al., 2010; Chen, et al., 2011; Navas-Acien et al., 2005). Immunological suppression
caused by arsenic has been related to the occurrence of several diseases and has been
addressed by many research groups (Dangleben et al., 2013). However, most of the
studies on arsenic immunotoxicity used high concentrations within low to high
micromolar. Since the accessible doses of arsenic in the environment are usually low
(Josyula et al., 2006), studying the immunotoxic effects of nanomolar doses of arsenic are
important for environmentally-relevant exposures. Previously, we demonstrated that As+3
had differential genotoxic effects in mouse DN thymus cells at low concentrations that
did not induce apoptosis (Xu et al., 2015). Therefore, the present study shows that As+3
and MMA+3 inhibits a critical signaling pathway in the same cell population via
nongenotoxic mechanism resulting in inhibition of pre-T cell differentiation.
IL-7 signaling is critical for early T cell development in thymus. It has been
showed that high concentrations of As+3 significantly inhibited γc receptor signaling such
as IL-2 and IL-6 (Cheng et al., 2004). Previously, we showed that MMA+3 had a strong
inhibitory effect on IL-7 signaling in pre-B cells within nanomolar range (Ezeh et al,
2015). The observation of a similar pattern of suppression by low concentrations of As+3
and MMA+3 in bone marrow Pre-B and thymic DN T cells suggests a common
mechanism of arsenic induced immunosuppression in lymphoid progenitor cells. Because
IL-7R (CD127) expression was decreased by MMA+3 in both systems, it is possible that
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receptor modulation, in addition to actions on downstream targets is responsible for
inhibition of STA5 signaling. Because 500 nM As+3 increased the receptor expression in
D1 cells, and did not affect CD127 expression in a pre-B cell model (Ezeh et al., 2015), it
is likely that As+3 suppression of IL-7 signaling occurs downstream of the receptor by
actions on JAK or STAT by modulating protein phosphorylation (Xue et al., 2011; Paul
et al., 2007). Therefore, the possibility that inorganic and organic forms of arsenic act by
different mechanisms in γc receptor signaling should be further explored.
As+3 is the prevalent form in nature. After the intake if As+3, MMA+3 is formed in
vivo through the action of arsenite-3-methyltransferase, which is highly expressed in the
liver (Aposhian et al., 2000). Previous studies have indicated that MMA+3 is more toxic
than As+3 (Orihuela et al., 2013; Petrick et al., 2000). In this study, MMA+3 was found to
be 10 times more effective in suppressing STAT5 and JAK1, 3 phosphorylations (Fig. 3.1
and 3.2). Trivalent arsenicals are known to induce toxicity by binding to thiol-containing
molecules (Styblo et al., 1995). The differences between As+3 and MMA+3 in protein
binding is that As+3 requires a structure with 3 cysteines, while MMA+3 needs only 2,
which significantly increases the numbers of its binding targets (Shen et al, 2013).
Therefore, it is possible that MMA+3 reacts directly on the IL-7R, resulting a suppression
of the downstream factor activations. As+3 is documented to inhibit zinc finger proteins
such as PARP (Zhou et al., 2011).
Since DN thymus cells are sensitive to As+3 and MMA+3 at low doses, the
immunosuppression induced by arsenic exposure may occur at very early stages of T cell
differentiation in the thymus. There are reports showing that prenatal arsenic exposures
are related to the altered lymphoid cell development and thymic atrophy (Ahmed et al.,
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2012; Raqib et al., 2009). It is very possible that these early life developmental
suppressions are associated with the high sensitivity of the DN T cell population.
Therefore, studies addressing the differences between the DN population and other
populations such as the DP T cells or mature T cells are also important for understanding
the mechanisms of arsenic induced immunosuppression in environmental exposures.
Collectively, As+3 and MMA+3 inhibit IL-7 signaling in mouse DN thymus cells at
environmentally relevant concentrations. The two forms of arsenic have differential
effective doses and may act through distinct mechanisms. The suppression of the IL-7
signaling result in the decrease of cyclin D1, a STAT5 transcriptionally-regulated cell
cycle protein, suggesting a mechanistic explanation of the reduction of the DN T cell
population, which exhibits high sensitivity to arsenic exposures.
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ABSTRACT

It is known in humans and mouse models, that drinking water exposures to
arsenite (As+3) leads to immunotoxicity. Previously, our group showed that certain types
of immune cells are extremely sensitive to arsenic induced genotoxicity. In order to see if
cells from different immune organs have differential sensitivities to As+3, and if the
sensitivities correlate with the intracellular concentrations of arsenic species, male
C57BL/6J mice were dosed with 0, 100 and 500 ppb As+3 via drinking water for 30 d.
Oxidation State Specific Hydride Generation- Cryotrapping- Inductively Coupled
Plasma- Mass Spectrometry (HG- CT- ICP- MS) was applied to analyze the intracellular
arsenic species and concentrations in bone marrow, spleen and thymus cells isolated from
the exposed mice. A dose-dependent increase in intracellular monomethylarsonous acid
(MMA+3) was observed in both bone marrow and thymus cells, but not spleen cells. The
total arsenic and MMA+3 levels were correlated with an increase in DNA damage in bone
marrow and thymus cells. An in vitro treatment of 5, 50 and 500 nM As+3 and MMA+3
revealed that bone marrow cells are most sensitive to As+3 treatment, and MMA+3 is more
genotoxic than As+3. These results suggest that the differential sensitivities of the three
immune organs to As+3 exposure are due to the different intracellular arsenic species and
concentrations, and that MMA+3 may play a critical role in immunotoxicity.
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HIGHLIGHTS



MMA+3 is the main species presented in bone marrow and thymus in As+3
exposed mice.



Bone marrow is the most sensitive lymphoid tissue to arsenic-induced
genotoxicity.



Increase in DNA damage is correlated with more intracellular MMA+3 in bone
marrow and thymus.



An in vivo exposure to 100 ppb As+3 induced genotoxicity in bone marrow and
thymus.



MMA+3 is more genotoxic than As+3 in vitro.
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INTRODUCTION

Arsenic (As) contamination in food and drinking water is a world-wide public
health issue. The trivalent inorganic form of As, arsenite (As+3), is the most prevalent
form in the environment. Exposure to As is associated with multiple diseases such as skin
lesions, diabetes, cardiovascular diseases, and cancers (Argos et al., 2010; SchuhmacherWolz et al., 2009; Vahter et al., 2008). Once As+3 gets into the body, it is metabolized
into monomethyl and dimethyl trivalent and pentavalent species (Aposhian and
Aposhian, 2006). Monomethylarsonous acid (MMA+3) has been shown to be more toxic
than As+3 both in vivo and in vitro (Petrick et al., 2001; Styblo et al., 2000). MMA+3 can
be further metabolized to dimethylarsonous acid (DMA+3) or dimethylarsinic acid
(DMA+5) and excluded from the body.
Arsenic induced immunotoxicity has been studied by many groups both in vitro
and in vivo (Ahmed et al., 2014; Nadeau et al., 2014; Biswas et al., 2008; Vahter et al.,
2008; Soto-Peña et al., 2006; Gonsebatt et al., 1994). However, only a few studies have
addressed the toxicity of As exposure to immune cells at environmentally relevant
concentrations. Previous studies in our laboratory showed that in vivo drinking water
exposure to As+3 at very low concentrations suppresses mouse bone marrow and spleen
cell functions (Ezeh et al., 2014; Li et al., 2010). Human peripheral blood mononuclear
cells (HPBMC) studies also showed a dose-dependent suppression of T cell proliferation
at extremely low concentrations of As+3 (0.1-10 nM) in some individuals, with virtually
all individuals susceptible to T cell immunosuppression by MMA+3 (Burchiel et al.,
2014). Therefore, lymphocytes are extremely sensitive to As+3 exposure at
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environmentally relevant levels. However, it is unclear whether immunotoxicity is likely
due to As+3 or MMA+3.
T cells are generated in bone marrow and transferred to the thymus for
development, while B cells develop in bone marrow. The spleen is a critical immune
organ for the storage of both T and B cells and for systemic immune responses. In a
previous study on the genotoxicity induced by As+3 in mouse thymus cells, we showed
that mouse thymus cells are extremely sensitive to As+3 induced DNA damage, which is
correlated with the inhibition of a base excision repair factor, Poly (ADP-ribose)
polymerase (PARP) (Xu et al., 2016b). In the present study, the sensitivities of the three
immune organs, bone marrow, spleen and thymus to As induced genotoxicity were
compared both in vivo and in vitro. The species and levels of intracellular arsenic
contents in the cells from the three immune organs were also determined and compared.
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METHODS

Chemicals and Reagents
Sodium arsenite (CAS 774-46-5, NaAsO2, Purity ≥ 90%) was purchased from
Sigma-Aldrich (St. Louis, MO). Methylarsine iodide (MMA+3) was obtained from Drs.
Terry Monks and Todd Caminesch at the Southwest Environmental Health Sciences
Center, University of Arizona. Penicillin/Streptomycin (Pen/Strep) and L-Glutamine
were purchased from Life Technologies (Grand Island, NY). Dulbecco’s phosphate
buffered saline w/o Ca+2 or Mg+2 (DPBS-) was purchased from Mediatech (Manassas,
VA). Dimethyl sulphoxide (DMSO), RPMI 1640 and Iscove’s Modified Dulbecco’s
Medium (IMDM) base medium were purchased from Sigma Aldrich. Fetal Bovine Serum
(FBS) was purchased from Atlanta Biologicals (Flowery Branch, GA). Hanks Balanced
Salt Solution (HBSS) was purchased from Lonza (Walkersville, MD). Sodium
Hydroxide (NaOH) was purchased from EMD Chemicals Inc. (Gibbstown, NJ). 0.5 M
EDTA solution was purchased from Promega (Madison, WI). The Comet Assay kit (Cat.
No. 4252-040-ESK), hOGG1 FLARE™ Assay kit (Cat. No. 4130-100-FK) and the
PARP activity kit (Cat. No. 4685-096-K) were purchased from Trevigen (Gaithersburg,
MD). The BCA assay kit (Cat. No. 23225) was purchased from Thermo Scientific
(Rockford, IL).
Mouse In Vivo Exposures
C57BL/6J male mice were purchased at 8 weeks of age from Jackson Laboratory
(Bar Harbor, ME). All animal experiments were performed following the protocols
approved by the Institutional Animal Use and Care Committee at the University of New
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Mexico Health Sciences Center. Following one week of acclimation, mice (2–3 per cage)
were exposed to As+3 at different concentrations via drinking water for 30 d. As+3 doses
were prepared fresh weekly by weighing each water bag and determining the appropriate
amount of stock As+3 solution to add to each bag to yield 100 and 500 ppb. No treatment
was added to control bags. Water bags were weighed after each week and the change in
weight was used to estimate the amount of water consumed by each group. The As+3
concentrations in drinking water were verified using Mass Spectrometry by Dr. AbdulMehdi S. Ali at Department of Earth and Planetary Sciences, University of New Mexico.
Mice were fed 2020X Teklad global soy protein-free extruded rodent diet (Envigo,
Indianapolis, IN) throughout the experiment.
Isolation of Bone Marrow Cells
Bone marrow cells were isolated according to the procedures described in Ezeh et
al., 2014. Basically, mouse femurs were collected into HBSS medium in our animal
facility and transferred to our laboratory to extract cells. Femurs were placed in petri dish
containing 5 ml of cold sterile bone marrow medium (500 ml IMDM with 2% FBS, 2
mM L-glutamine, and 100 mg/ml Pen/Strep) and trimmed to expose interior marrow
shaft of the femur, the end of the femur were then cut off. one cc syringe and 25 gauge
needle were used to flush the bone marrow medium through the femur several times to
release cells into the petri dish. The suspension was immediately transferred to a 15 ml
centrifuge tube, centrifuged at 200 xg for 10 min, aspirated, and washed with bone
marrow medium. The cell count and viability were determined by acridine
orange/propidium iodide (AO/PI) staining on a Nexcelom Cellometer 2000.
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Isolation of Thymus and Spleen Cells
Thymus and spleen were isolated following the sterile procedures described in
Xu, et al., 2016. Basically, mouse thymus and spleen were harvested in our animal
facility and transferred to the laboratory in HBSS on ice. Single cell suspensions of
spleen and thymus cells were prepared by homogenizing the organ between the frosted
ends of two sterilzed microscope slides (Fisher Scientific, Pittsburgh, PA) into a dish
containing 5 mL of cold mouse medium (500 ml RPMI 1640 with 10% FBS, 2 mM Lglutamine, and 100 mg/ml Pen/Strep). Suspended cells were centrifuged at 200 xg for 10
min, aspirated, and washed with mouse medium. The cell count and viability were
determined by AO/PI staining on a Nexcelom Cellometer 2000.
Oxidation state specific Hydride Generation- Cryotrapping- Inductively Coupled
Plasma- Mass Spectrometry (HG- CT- ICP- MS)
The analysis of tri- and pentavalent As species was performed by HG-CT-ICPMS as previously described (Currier et al., 2014; Matousek et al., 2013). Briefly, cell
pellets were lysed in ice-cold deionized water. The trivalent species, As3+, MMA3+, and
dimethylarsinite (DMA3+) were measured in an aliquot of cell lysate directly, without
pretreatment. Another aliquot was treated with 2% cysteine and analyzed for total
inorganic As (As3+ + As5+), total methyl-As (MMA3+ + MMA5+), and total DMAs
(DMA3+ + DMA5+). Calibration curves were generated using cysteine-treated pentavalent
As standards, (at least 98% pure) as previously described (Hernández-Zavala et al.,
2008). The concentrations of pentavalent As species were determined as a difference
between the values obtained for cysteine-treated aliquots and values from untreated
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sample aliquots. The instrumental LODs for As species analyzed by HG-CT-ICP-MS
ranged from 0.04 pg As for methylated arsenicals to 2.0 pg As for inorganic arsenicals.
In Vitro As+3 and MMA+3 Treatments
Bone marrow, spleen and thymus cells were isolated as described above from
three 13-week old male C57BL/6J mice and pooled. Cells were washed and resuspended
at 1 x 106 cells/ml in IMDM (for bone marrow cells) or mouse medium (for spleen and
thymus cells). As+3 or MMA+3 were added to each wells to the final concentrations of 0
(control), 5, 50 and 500 nM. Cells were placed into a humidified 37 °C, 5% CO2
incubator for 4 h. Treated cells were harvested by centrifugation at 200 xg for 10 min and
resuspended in cold DPBS-. After another wash with cold DPBS-, the cells were ready for
Comet assay analysis.
Comet Assay (Single Cell Gel Electrophoresis Assay) and Fragment Length Analysis
using Repair Enzymes (FLARE ) Assay
Treated cells were immobilized in a bed of low melting point agarose on a
Trevigen CometSlide™ following the Comet assay kit instructions. Cells were then lysed
with Lysis Solution with 10% DMSO (Sigma-Aldrich) over night. On the next day, DNA
in the lysed cells were unwound with basic buffer (8 g NaOH with 500 mM EDTA in 1 L
of Milli-Q water, pH>13) at room temperature for 45 min. For FLARE assay, human 8oxoguanine DNA glycosylase 1 (hOGG1) from the FLARE kit was diluted to 1:5 and
applied to the wells. Slides were then incubated at 37 °C for 30 min before adding the
unwinding buffer. For both assays, slides were electrophoresed in ice cold basic buffer
with 21 volts for 30 min. Slides were washed, dried and stained with Sybr Gold (1:10000
dilution in TE buffer) and imaged using an epifluorescence microscope. Fifty randomly
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selected cells from each well were scored using CometScore software (TriTek Corp.,
Sumerduck, VA). DNA damage was reported by percentage of DNA in tail (Collins,
2004).
PARP activity assay
The PARP activity assay was performed using the Trevigen PARP activity kit.
All reagents were supplied by the kit unless otherwise specified. The procedures were
previously described by Sun et al., 2012. Basically, cells were lysed with the Cell
Extraction Buffer supplied in the kit, and the protein concentration was determined by the
BCA Protein Assay. Two hundreds ng of total proteins from each sample was combined
with activated DNA and nicotinamide adenine dinucleotide (NAD) supplied by the kit,
and then placed into a histone-coated strip well to formed PAR complex which was fixed
to the bottom of the well. Anti-PAR monoclonal antibody was then added to the well to
bind to PAR complex, followed by a Horseradish peroxidase (HRP) conjugated
secondary antibody against the primary antibody. TACS- Sapphire™ was used a
substrate to generate the chemiluminescence signal. An equal amount of 0.2 M HCl was
added to stop the reaction. The signals were detected using SpectraMax® 340PC
microplate reader (Molecular Devices, Sunnyvale, CA) at 450 nm wavelength.
Statistics
Data were analyzed using Excel 2013 and Sigma Plot v12.5 software. One-way
analysis of variance (ANOVA) and Dunnett’s t-test were used to determine differences
between the control and treatment groups. Pearson Correlation and polynomial linear
regression were used to analyze the correlations between intracellular As concentrations
and DNA damage increases. For in vivo As+3 treatment, 5 animals (n=5) were assigned to
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each treatment group. For the in vitro experiments, three replicates were performed and
analyzed for each dose.
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RESULTS

Intracellular arsenic species in the bone marrow, spleen and thymus cells of
drinking water exposed mice
9-week old C57BL/6J male mice were exposed to 0, 100, and 500 ppb As+3
through drinking water for 30 d. No change in mouse body weight or water intake was
observed during or after the exposure (Table 4.1). As+3 intake was calculated from the
water intake of each mouse and the As+3 concentrations in the drinking water determined
by mass spectrometry. Bone marrow, spleen and thymus were harvested from each
mouse and the cells were isolated. Although not statistically significant, there was a
trend of decrease in thymus weight, as well as the bone marrow and thymus cell
recoveries (Table 4.1). The spleen weight and cell recovery were not affected by As+3
exposure. In order to measure the intracellular species and amounts of arsenic in these
tissues from As+3 exposed mice, we used a very sensitive HG- CT- ICP- MS system to
analyze the intracellular As levels in 5 x 106 cells pelleted from each tissue, as well as 50
µl plasma from each mouse (Table 4.2). A dose-dependent increase in total intracellular
As levels was observed in bone marrow, spleen and plasma but not the spleen. Control
mice showed detectable levels of As, presumably due to small amounts of As present in
food and City of Albuquerque drinking water, which has As levels less than 5 ppb.
Interestingly, the major increased As species in bone marrow and thymus was the
trivalent methylated form, MMA+3, which was almost undetectable in 500 ppb exposed
spleen cells. Therefore, these results not only demonstrated that spleen is the least
exposed tissue among the three immune organs, but also indicated that MMA+3 may be
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the major cause of genotoxicity in As+3 in vivo exposures. The concentrations of arsenic
in plasma were an order of magnitude higher than those in cells from immune tissues;
here DMA+3 and DMA+5 are the major metabolites.

91

Table 4.1. Mouse body weight, water, arsenic (As) intake, tissue weight, cell recovery
and viability of 30 d 0 (Cont), 100 and 500 ppb As+3 in vivo drinking water exposed male
C57/BL6 mice1.
Treatments
Cont
100 ppb
500 ppb

Mouse body
weight (g)
27.71 ± 1.66
27.53 ± 2.69
27.50 ± 1.42

Water intake (ml/d)

As intake (ng/d)2

3.34 ± 0.11
3.68 ± 0.27
3.59 ± 0.34

18.50 ± 0.77
420. 54± 12.32*
2111.32 ± 323.19*

Cell recovery (x 106
Viability (%)
cells)
Bone
Cont
51.35 ± 12.75
86.16 ± 2.93
Marrow
100 ppb
42.78 ± 4.82
88.64 ± 1.72
500 ppb
43.14 ± 8.12
87.46 ± 2.10
Spleen
Cont
106 ± 6.60
186.6 ± 13.39
77.72 ± 3.19
100 ppb
106 ± 6.04
183.4 ± 14.31
74.75 ± 1.71
500 ppb
103 ± 10.03
180.8 ± 30.96
76.32 ± 2.65
Thymus
Cont
52.32 ± 7.31
71.32 ± 14.50
87.16 ± 1.56
100 ppb
46.24 ± 5.73
69.62 ± 17.24
87.68 ± 1.20
500 ppb
40.88 ± 11.69
60.34 ± 16.85
87.98 ± 0.89
1
Mice were 9-week old when the exposure started. 5 mice (n = 5) were treated for each
single dose. Drinking water was changed each week and water intake was calculated
from the change in the weight of the water. Cell recovery and viability were obtained
using a Cellometer 2000 with AO/PI staining. Results are Means ± SD.
2
As intake was calculated based on drinking water samples measured by Mass
Spectrometry and daily water intake of each mouse.
*Significantly different from Control (p < 0.5).
Tissue weight (mg)
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Table 4.2. Arsenic (As) species and amounts in bone marrow, spleen, thymus cells (5 x
106 cells), and 50 µl plasma in C57/BL6 male mice exposed to 0 (Cont), 100 and 500 ppb
As+3 in vivo for 30 d. Samples were analyzed by Oxidation State Specific Hydride
Generation- Cryotrapping- Inductively Coupled Plasma- Mass Spectrometry (HG- CTICP- MS)1.
Tissues

Bone
Marrow

Exposure
doses

As+3

Cont

ND

100 ppb

ND

500 ppb

ND

Cont
Spleen

100 ppb
500 ppb
Cont

Thymus

Plasma

100 ppb

0.29
±
0.10
0.11
±
0.08
0.51
±
0.26
2.62
±
0.91
5.51
±
2.49

As amount by species (pg)
DMA+3
As+5
MMA+5
0.52 ±
5.46 ±
0.03 ±
ND
0.10
0.74
0.01
0.07 ±
1.77 ±
7.60 ±
0.34 ±
0.04
0.73*
1.78
0.15*
11.70
45.70 ± 4.13 ± 0.
10.35 ±
±
0.69
85*
1.31*
3.54*

MMA+3

DMA+5
0.88 ±
0.13
2.02 ±
0.21*

Total As
6.88 ±
0.63
11.80 ±
2.49*

7.52 ±
3.12*

79.44 ±
8.47*

ND

0.16 ±
0.12

10.14
± 1.90

0.43 ±
0.41

0.51 ±
0.07

11.21 ±
2.19

0.12 ±
0.05

0.97 ±
0.71

11.62
± 2.89

0.29 ±
0.08

0.66 ±
0.33

13.73 ±
2.79

0.22 ±
0.17

1.83 ±
0.42*

11.33
± 2.86

1.61 ±
2.13

1.15 ±
0.27*

16.45 ±
3.54

0.13 ±
0.10

0.44 ±
0.18

11.86
±
3.01

0.61 ±
0.86

0.22 ±
0.14

15.83 ±
3.06

25.70 ±
4.50*

0.81 ±
0.16

14.34
± 6.40

8.08 ±
1.86*

0.63 ±
0.07*

54.42 ±
10.10*

125.43 ±
21.23*
3.79 ±
2.561

3.17 ±
2.01*
138.92 ±
13.00

500 ppb

ND

Cont

ND

100 ppb

ND

2.40 ±
0.50

363.87 ±
131.87*

500 ppb

ND

12.72 ±
4.92*

802.84 ±
66.46*

1

NA
NA
43.36
±
21.12
63.56
±
25.92

3.47 ±
3.59
9.72 ±
9.86

226.76 ±
17.11

28.59 ±
7.57*

639.43 ±
144.39*

57.07 ±
17.58*

2027.22
±
358.66*

NA

146.79 ±
43.34*
386.35 ±
21.54
1077.66
±
381.32*
2963.41
±
332.48*

5 mice (n = 5) were treated for each single dose. Sample lost happened during
collections and injections. Values are in picograms (pg). Results are Means ± SD.
NA, n < 3 due to sample lost.
ND, below detection range.
*Significantly different from Cont (p < 0.5).
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Differential sensitivities of bone marrow, spleen and thymus in DNA damage and
PARP activity to in vivo arsenic exposures
To compare the genotoxicity between lymphoid tissues, we performed Comet
Assay on the cells obtained from the spleen, thymus, and bone marrow. Results showed
a significant increase in DNA damage in both bone marrow and thymus cells starting at
100 ppb (Fig. 4.1A and 4.1C). No increase of DNA damage was observed in spleen cells
(Fig. 4.1B). The activity of PARP was also measured as a common endpoint to see if the
DNA repair ability was also inhibited. Arsenic is known to cause PARP inhibition, which
has been shown to result in increased DNA damage (Qin et al., 2008; Xu et al., 2016b;
Zhou et al., 2011). A dose-dependent decrease in PARP activity was seen in bone
marrow and thymus cells (Fig. 4.2A and 4.2C). No change in PARP activity was
observed in spleen cells (Fig. 4.2B). These results showed that bone marrow and thymus
cells are more prone to genotoxicity compared to spleen cells, which may be the result of
higher intracellular As and MMA+3 concentrations in in vivo exposures.
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Figure 4.1. DNA damage in bone marrow, spleen and thymus cells from 30 d As+3
drinking water exposed mice. 9-week old male C57BL/6J mice were exposed to 0, 100
and 500 ppb As+3 through drinking water for 30 d. Bone marrow, spleen and thymus
cells were isolated and the DNA damage was measured by Comet assay. A, bone
marrow. B, spleen. C, thymus. *Significantly different compared to control (p<0.05,
n=5). Results are Means ± SD.
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Figure 4.2. PARP activity in bone marrow, spleen and thymus cells from 30 d As+3
drinking water exposed mice. 9-week old male C57BL/6J mice were exposed to 0, 100
and 500 ppb As+3 through drinking water for 30 d. Bone marrow, spleen and thymus
cells were isolated and the PARP activity assay was used to measure the PARP activity in
the cell protein lysates. A, bone marrow. B, spleen. C, thymus. *Significantly different
compared to control (p<0.05, n=5). Results are Means ± SD.
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Correlations between DNA damage increase and intracellular arsenic
concentrations in bone marrow, spleen and thymus cells
In vivo exposures to As+3 resulted a dose-dependent increase in total As and
MMA+3 intracellular concentrations in bone marrow and thymus cells. We performed a
regression analysis to reveal the relationships between total As or MMA+3 intracellular
levels and the DNA damage in bone marrow, spleen and thymus cells. As shown, the
amount of DNA damage correlated with the intracellular total As as well as the MMA+3
levels in bone marrow and thymus cells (Fig. 4.3A, 4.3C, 4.3D and 4.3F). There was no
correlation between the DNA damage and intracellular As in the spleen cells (Fig. 4.3B
and 4.3E). This analysis demonstrated that higher in vivo exposure to As+3 can increase
the intracellular total As and MMA+3 in the bone marrow and thymus cells, which may
induce or increase DNA damage in these immune tissues.
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Figure 4.3. Correlations between intracellular total As or MMA+3 concentrations and
DNA damage in bone marrow, spleen and thymus cells from 30 d As+3 drinking water
exposed mice. A, total As and DNA damage in bone marrow cells. B, total As and DNA
damage in spleen cells. C, total As and DNA damage in thymus cells. D, MMA+3 and
DNA damage in bone marrow cells. E, MMA+3 and DNA damage in spleen cells. F,
MMA+3 and DNA damage in thymus cells.
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Differential sensitivities of bone marrow, spleen and thymus in DNA damage to in
vitro arsenic exposures

In order to see if the differential sensitivities observed between spleen, thymus
and bone marrow were due to different cell type susceptibilities, we directly added As+3
and MMA+3 to primary cultures of these cells. Cells were isolated and treated with 5, 50
and 500 nM As+3 or MMA+3 in vitro for 4 h and then were assessed for DNA damage
using Comet assay. As shown in Fig 4.4A, bone marrow cells were sensitive to As+3 at
concentrations as low as 5 nM. Spleen and thymus cells were only sensitive to As+3
treatment at the high concentration (500 nM, Fig. 4.4B and 4.4C). However, cells from
all the three organs were sensitive to MMA+3 starting at the 5 nM concentration,
indicating that MMA+3 is more genotoxic than As+3 in vitro. It was also observed that
bone marrow cells seemed to be the most sensitive among all the three organs. However,
the sensitivities of spleen and thymus were comparable in vitro, indicating that the lower
sensitivity in spleen cells observed in the in vivo experiment was due to lower As
accumulation. The FLARE assay is a modified type of Comet assay that uses hOGG1 to
enhance its sensitivity to detect oxidative DNA damage (Smith et al., 2006). We
performed the FLARE assay with same samples used for the Alkaline Comet assay
following 4 h incubation with As+3 and MMA+3. The results obtained from the FLARE
assay were similar to the Comet assay, except that a significant increase in DNA damage
was observed at high doses of As+3 and MMA+3 only in thymus cells (Fig. 4.4C). This
observation is consistent with our previous findings that As+3 induced oxidative stress in
thymus cells at high concentrations (Xu et al., 2016b). These results demonstrated that
bone marrow, spleen and thymus cells are more sensitive to MMA+3 induced
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genotoxicity than As+3 in vitro, indicating that the higher sensitivities of bone marrow
and thymus cells in in vivo exposures were likely due to the significantly increased
MMA+3 intracellular concentrations.
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Figure 4.4. DNA damage in bone marrow, spleen and thymus cells treated with As+3 and
MMA+3 in vitro for 4 h. Cells were isolated from three 13-week old C57BL/6J mice and
pooled. Bone marrow, spleen and thymus cells were then treated with 5, 50 and 500 nM
As+3 or MMA+3. Comet assay and FLARE assay were used to analyze the DNA damage
and oxidative damage induced by the treatments. A, bone marrow. B, spleen. C, thymus.
*Significantly different compared to control (p<0.05). #Significantly different compared
to the Comet assay (p<0.05) Results are Means ± SD.
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DISCUSSION

As+3 is known to cause multiple and complicated biological effects. There have
been many studies focusing on the toxicity of As+3 over the years. However, two basic
questions are often ignored when we set up the biological models and expose animals or
cells to As+3. What is the actual level of exposure and what chemical species are
responsible for immunotoxicity in various lymphoid tissues? From previous studies, we
know that various inorganic and organic arsenic species have differential toxicities (Akter
et al., 2005). From studies in our laboratory, we have found that cells from different
immune organs and tissues have differential sensitivities to As (Ezeh et al., 2014, 2016;
Li et al., 2010; Xu et al., 2016a, 2016b). Therefore, it is important to determine if
lymphoid organs and tissues, such as bone marrow, spleen and thymus have differential
sensitivities to As+3 in terms of genotoxic and non-genotoxic actions both in vivo and in
vitro.
In this study, intracellular As concentrations and species were measured in
lymphoid cells isolated from three immune organs following As+3 30 d drinking water
exposure. A correlation between increased DNA damage and increased intracellular
MMA+3 levels were found in both bone marrow and thymus cells (Fig. 1 and Table 1).
Spleen cells were not as sensitive as bone marrow and thymus cells in vivo, and the
intracellular MMA+3 levels in the spleen were not as high as seen in bone marrow and
thymus, which can be the reason that caused the sensitivity differences. T and B cells in
the spleen are more mature than those in the bone marrow and thymus, which might be a
factor that accounts for the differential intracellular As concentrations. One of our
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previous studies showed that the thymus cells at the earlier stage (double negative) are
more prone to As+3 induced toxicity than the later stage (double positive) (Xu et al.,
2016a). Therefore, it is possible that more mature cells are resistant to As toxicity, due to
a lower intracellular As concentration or less toxic intracellular As species. Another
observation that supports this hypothesis is that bone marrow cells were sensitive to even
5 nM As+3 exposure in vitro (Fig. 4.1A). Bone marrow consists of multiple types of early
progenitor cells and the very early stage of pre-T cells that migrate to the thymus. It is
important to understand potential mechanisms responsible for the susceptibility of early
lymphoid cells to As toxicity. Also, in the Comet assay experiments, we noticed that it is
very common for bone marrow cells to have higher background DNA damage from in
vivo exposures, which may also due to the fragility of the progenitor cells in the bone
morrow.
MMA+3 has been shown to be more toxic than As+3 in lymphoid and nonlymphoid tissues. MMA+3 is formed in vivo mostly in the liver, kidneys, and lungs under
the influence of the AS3MT enzyme (Chen et al., 2011). We have found little enzyme
expression of AS3MT in mouse lymphoid tissue, and have found little evidence for
metabolism of As+3 in lymphoid tissues (unpublished data). Thus we believe that the
presence of MMA+3 in lymphoid tissues is a reflection of MMA+3 uptake from the blood.
From Table 2, we know that although the prevalent forms of As species in the plasma are
MMA+5, DMA+3 and DMA+5, MMA+3 concentration was also significantly increased in
the high dose. On the other hand, MMA+3 was the most prevalent form in high dose
exposed bone marrow and thymus cells. Also, there was As+5 in cells from all three
tissues, but As+3 was almost undetectable in all three tissues. Therefore, we think that the
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differences in bone marrow and thymus compared to spleen may result from a difference
in the ability of cells either to import or export As+3 and MMA+3 or to convert MMA+5 to
MMA+3. Our current efforts are aimed at measuring these differences.
Regarding the mechanism of DNA damage produced by MMA+3, it has been
found that MMA+3 may produce stronger inhibition than As+3 of PARP, a zinc finger
protein that is required for base excision repair, (Sun et al., 2012; Zhou et al., 2014). In
our previous studies, we demonstrated a correlation between PARP activity inhibition
and the increase of DNA damage in mouse thymus cells (Xu et al., 2016b). Therefore, the
DNA damage increase observed in the mouse bone marrow and thymus cells following in
vivo As+3 exposure appears to result from suppression of the DNA repair system.
In summary, the present study showed differential sensitivities of the cells from
three important immune organs, bone marrow, spleen and thymus, to As+3 induced
genotoxicity in vivo. The in vivo sensitivity was shown to be correlated with an increase
in the trivalent methylated arsenic species, MMA+3. Bone marrow cells were shown to be
the most sensitive in vitro, which may relate to the maturity of the cell types in different
tissues. These studies stress the importance of measuring lymphoid tissue exposure and
performing speciation analyses for arsenic studies.
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ABSTRACT

Arsenic and polycyclic aromatic hydrocarbon (PAH) exposures affect many
people worldwide leading to cancer and other diseases. Arsenite (As+3) and certain PAHs
are known to cause genotoxicity. However, there is limited information on the
interactions between As+3 and PAHs at environmentally relevant concentrations. The
thymus is the primary immune organ for T cell development in mammals. Our previous
studies showed that environmentally relevant concentrations of As+3 induce genotoxicity
in mouse thymus cells through Poly(ADP-ribose) polymerase (PARP) inhibition. Certain
PAHs, such as the metabolites of benzo(a)pyrene (BaP), are known to cause DNA
damage by forming DNA adducts. In the present study, primary mouse thymus cells were
examined for DNA damage following 18 hr in vitro treatments with 5 or 50 nM As+3 and
100 nM BaP, benzo[a]pyrene-7,8-dihydrodiol (BP-Diol), or benzo[a]pyrene-7,8dihydrodiol-9,10-epoxide (BPDE). Increase of genotoxicity and apoptosis were observed
following treatments with 5 nM As+3 + 100 nM BP-Diol and 50 nM As+3 + 100 nM
BPDE. We attribute the increase in DNA damage to inhibition of PARP inhibition
leading to decreased DNA repair. To further support this hypothesis, we found that a
PARP inhibitor, 3,4-dihydro-5[4-(1-piperindinyl) butoxyl]-1(2H)-isoquinoline (DPQ),
also interacted with BP-diol to produce an increase in DNA damage. Interestingly, we
also found that As+3 and BP-diol increased CYP1A1 and CYP1B1 expression, suggesting
that increased PAH metabolism may also contribute to genotoxicity. In summary, these
results show that the suppression of PARP activity and induction of CYP1A1/CYP1B1
may act together to increase DNA damage produced by As+3 and PAHs.
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INTRODUCTION

Polycyclic aromatic hydrocarbons (PAHs) are widespread organic pollutants,
which naturally occur in soil, air, and following the burning of fossil fuels. PAHs are
generated from combustion of wood, coal, oil and tobacco, and they are also abundant in
overcooked and processed foods. The toxicity of PAHs is dependent on their structures.
Benzo(a)pyrene (BaP), a Group One carcinogen listed by International Agency for
Research on Cancer, has been associated with increased levels of colon cancer (Le
Marchand et al., 2002), as well as genotoxicity in the lung of smokers (Denissenko et al.,
1996). BaP is considered a pro-carcinogen, as metabolism and activation by CYP1A1,
CYP1B1 and epoxide hydrolase are required to cause cancer (Jones et al., 1995; Shimada
and Fujii-Kuriyama, 2004). BaP is first metabolized to benzo[a]pyrene-7,8-dihydrodiol
(BP-Diol), which is then converted into benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide
(BPDE). BPDE binds covalently to DNA forming adducts resulting in DNA damage and
mutation (Kim et al., 1998; Schwarz et al., 2001). The expression of CYP1A1 and
CYP1B1 is regulated by aryl hydrocarbon receptor (AhR), which has been shown to be
induced by BaP (Hockley et al., 2007).
Arsenic exposure from food and drinking water sources is a world-wide public
health concern. Environmental exposures of arsenic can range from several to several
hundred ppb (10 ppb ≈ 130 nM) for different areas and populations (Rahman et al., 2006;
Sherwood et al., 2013). The trivalent from of inorganic arsenic, arsenite (As+3), has been
associated with many diseases such as diabetes, skin lesions, and cancers (Argos et al.,
2010; Schuhmacher-Wolz et al., 2009; Vahter, 2008). One of the primary genotoxic
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mechanisms of As+3 is the inhibition of DNA repair (Faita et al., 2013). As+3 has been
shown to compete with Zn+2 on C3H1 and C4 zinc fingers, decreasing the activity of zinc
finger proteins involved in DNA repair such as Poly(ADP-ribose) polymerase (PARP)
and Xeroderma Pigmentosum, Complementation Group A (XPA) (Qin et al., 2012; Zhou
et al., 2011; Zhou et al., 2014). Our previous studies demonstrated a dose-dependent
increase in DNA damage and PARP inhibition in mouse thymocytes (Xu et al., 2016). At
environmentally relevant concentrations, DNA damage induced by As+3 in thymic cells
appears to result from PARP inhibition at low exposure levels (e.g., 50 nM As+3). Higher
in vitro exposure levels (e.g., 500 nM As+3) result in oxidative stress that is associated
with more DNA damage and double strand breaks. The findings are in agreement with
those obtained by other groups (Litwin et al., 2013; Qin et al., 2012). There is also
evidence showing that PARP contributes to XPA repair of double strand breaks (King et
al., 2012).
As+3 has been documented to interact with other environmental agents, such as
UVR (Cooper et al., 2009; Cooper et al., 2013; Evans et al., 2004; Zhou et al., 2011).
There is also evidence showing that co-exposure with As+3 increases BaP DNA adduct
formation and mutations in mouse hepatoma Hepa-1 cells in vitro (Maier et al., 2002).
An in vivo study revealed that arsenic co-exposure can increase BaP adducts formation in
both lung and skin (Evans et al., 2004). However, studies have not addressed the effects
of As+3 and PAH co-exposure on immune cells in the thymus.
Our previous studies revealed that As+3 interacted with PAHs to increase the
suppression of progenitor pre-B cell formation in murine bone marrow at very low
concentrations both in vitro and in vivo (Ezeh et al., 2014; Ezeh et al., 2015). Synergistic
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immunosuppression of T-dependent antibody responses by different PAHs and As+3
spleen cells were also observed (Li et al., 2010). Evidences also indicated that human T
cells from certain healthy individuals were suppressed by extreme low concentrations (1100 nM) of As+3 in vitro (Buechiel et al., 2014). Thymocytes are primarily early T cells
which have been shown to be very sensitive to As+3 induced genotoxicity, which can
occur at low exposure levels not associated with oxidative stress (Xu et al., 2016).
Therefore, our hypothesis is that co-exposure of low concentrations of As+3 and PAHs
will induce genotoxicity in mouse thymus cells.
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MATERIALS AND METHODS

Chemicals and Reagents
Sodium arsenite (As+3, CAS 774-46-5), benzo(a)pyrene (BaP, CAS 50-32-8),
benzo(e)pyrene (BeP, CAS 192-97-2), anthracene (ANTH, CAS 120-12-7),
dibenz(a,c)anthracene (DAC, CAS 215-58-7), dibenz(a,h)anthracene (DAH, CAS 53-703), 3-methylcholanthrene (3-MC, CAS 56-49-5), benz(a)anthracene (BA, CAS 56-55-3),
7,12-dimethylbenz(a)anthracene (DMBA, CAS 57-97-6), 9,10-dimethylanthracene
(DMA, CAS 781-43-1) were purchased from Sigma-Aldrich (St. Louis, MO).
Dibenzo(def,p)chrysene (DBC, CAS 191-30-0) was purchased from AccuStandard (New
Haven, CT). BaP-trans-7,8-dihydrodiol (BP-diol), BaP-trans-7,8-dihydrodiol-9,10epoxide (BPDE) and DMBA-trans-3,4-dihydrodiol (DMBA-diol), 11,12-dihydroxy11,12-dihydrodibenzo(def,p)chrysene (DBC-diol) were obtained from National Cancer
Institute Chemical Repository (Midwest Research Institute, Kansas City, MO). Hanks
Balanced Salt Solution (HBSS) was purchased from Lonza (Walkersville, MD).
Penicillin/Streptomycin 10,000 (mg/ml)/10,000 (U/ml) and 200 mM L-Glutamine were
purchased from Life Technologies (Grand Island, NY). Dulbecco’s phosphate buffered
saline w/o Ca+2 or Mg+2 (DPBS-) and RPMI 1640 HEPES modified medium base,
sodium azide and dimethylsulfoxide (DMSO) were purchased from Sigma-Aldrich. Fetal
Bovine Serum (FBS) was purchased from HyClone Laboratories (Logan, UT). 3,4Dihydro-5[4-(1-piperindinyl) butoxyl]-1(2H)-isoquinoline (DPQ, CAS 129075-73-6) was
purchased from Santa Cruz Biotechnology (Dallas, TX). HT chemiluminescent
PARP/apoptosis assay kit (Cat. No. 4685-096-K) and CometAssay® 20 well ES starter
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kit (Cat. No. 4252-040-ESK) were purchased from Trevigen (Gaithersburg, MD).
Pierce™ BCA protein assay kit (Cat. No. 23225) was purchased from Thermo Fisher
Scientific (Waltham, MA). FITC Annexin V Apoptosis Detection Kit II (Cat. No.
556570) was purchased from BD Biosciences (San Jose, CA). RNeasy Mini Kit ™ and
QIAshredder™ were purchased from Qiagen (Valencia, CA). High Capacity cDNA
reverse transcription kit (Cat. No. 4368814), CYP1A1 (Mm00487218_m1)/ CYP1B1
(Mm00487229_m1) TaqMan® gene expression assays and TaqMan® universal PCR
master mix (Cat. No. 4304437) and Dihydroethidium (DHE, Cat. No. D11347) were
purchased from Life Technologies. CYP1A1/1B1 P450-GloTM assay (Cat. No. V8751)
was purchased from Promega (Madison, WI).
Isolation of primary mouse thymus cells
8 to 10 week old C57BL/6J male mice were purchased from Jackson Laboratory
(Bar Harbor, ME). All animal experiments were performed following protocols approved
by the Institutional Animal Use and Care Committee at the University of New Mexico
Health Sciences Center. Thymuses were harvested and transferred to the laboratory in
HBSS. Cell suspensions from 3 mice were pooled, centrifuged at 200 x g for 10 min and
resuspended in the mouse medium (RPMI 1640 plus 10% FBS, 2 mM L-glutamine, 100
mg/ml streptomycin, 100 units/ml penicillin). Cell viability was determined by acridine
orange/propidium iodide (AO/PI) staining and counting using the Nexcelom Cellometer
2000.
The single cell gel electrophoresis assay (Comet assay)
Cells were treated in vitro and washed with DPBS-, immobilized in a 1.5 ml
microcentrifuge tube containing 250 μl low melting point agarose and then applied to a
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Trevigen CometSlide™. Cells were lysed with Lysis Solution with 10% DMSO, and
electrophoresed in NaOH buffer (pH>13) with 21 volts for 30 min. Slides were air dried,
stained with Sybr Green and imaged with an Olympus IX70 inverted fluorescence
microscope. 50 cells from each well of the slides were scored using CometScore (TriTek
Corp., Sumerduck, VA).
PARP activity ELISA assay
After harvest, in vitro treated cells were lysed with Cell Extraction Buffer from
the kit and the protein concentration of each lysate was quantified by BCA protein assay.
200 ng of total protein was combined with activated DNA and nicotinamide adenine
dinucleotide (NAD) to form PAR, which became fixed on the bottom of histone-coated
strip wells. Anti-PAR monoclonal antibody was added to the wells to target PARP and
HRP conjugated secondary antibody was added to bind the primary antibody. TACSSapphire™ was used to generate the chemiluminescence signal. The reaction was
stopped by adding 0.2 M HCl. Absorbance was read at 450 nm using SpectraMax®
340PC microplate reader (Molecular Devices).
Annexin V/Propidium Iodide staining
1 x 105 cells were washed twice with DPBS- and resuspended in 100 μl 1X
Annexin V Binding Buffer. 5 μl of FITC Annexin V and 5 µl of Propidium Iodide
staining solution were added to each sample. After 15 min incubation at room
temperature in dark, 400 µl of 1X Annexin V Binding Buffer was added to each sample.
BD AccuriTM C6 flow cytometer was used to analyze the samples. Thymus cells treated
with 10 μM Etoposide for 4 h were used as positive control. For negative control, 5 μg of
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purified recombinant Annexin V was added to thymus cells to block the FITC conjugated
Annexin V binding.
DHE staining
1 mg DHE was suspended with 158 µl DMSO. 5 µl of the suspended DHE was
diluted with 20 ml DPBS- to a final concentration of 5 µM. 1 x 106 treated thymus cells
were washed twice with cold wash buffer (DPBS- +1% FBS +0.9% sodium azide). Each
sample was stained using 100 µl 5 µM DHE in DPBS- with 37 °C incubation for 30 min.
Cells were then washed with cold wash buffer, resuspended in 500 µl DPBS- and
analyzed on BD AccuriTM C6 flow cytometer. Thymus cells treated with 100 µM H2O2
for 10 min at 37 °C were used as positive controls.
RNA isolation and CYP1A1/1B1 RT-qPCR
RNA isolation was conducted following the instruction manual for the RNeasy
Mini Kit ™ and QIAshredder™ supplied by the manufacturer. The amount of extracted
RNA was then quantified on an Agilent Nanodrop spectrophotometer. For each reverse
transcriptase (RT) reaction, 60 µl containing a minimum of 1080 ng RNA was run on
SimpiAmps thermal cycler (Life Technologies) using the high capacity cDNA reverse
transcription kit. Samples were then diluted to ~9 ng/ µl with RNase, DNase free water
and stored at -20 °C. Real time PCR (qPCR) reactions were performed with TaqMan®
gene expression assays of CYP1A1 and CYP1B1 on Applied Biosystem’s 7900HT
system. Comparative CT (first amplification cycle exceeding threshold) was applied for
relative quantification, and GADPH gene was used as the endogenous control. The
method to calculate the comparative CT is described in detail in the manual from Life
Technologies.
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CYP1A1/1B1 activity assay
The CYP1A1/1B1 substrate, Luciferin-CEE was supplied in the P450-GloTM
assay. Experiment was performed followed the lytic assay protocol provided by Promega.
Isolated primary thymus cells were treated with As+3, BP-diol/BPDE and their
combinations for 18 h. Luciferin-CEE was then added to the culture, and the cells were
incubated for another 3 h at 37 °C. Then 50 µl of cells were combined with equal amount
of Luciferin substrate resuspended in the reconstitution buffer, transferred to a 96-well,
white polystyrene plate, and incubate at RT for 20 min. Luminescence was recorded on a
Tecan Infinite 200 (Männedorf, Switzerland).
Statistics
Excel 2010 and Sigma Plot 12.5 software were used for data analysis. One-way
analysis of variance (ANOVA) and Dunnett’s t-test were used to determine differences
between groups. Three replicates were performed and analyzed for each single dose. CDI
(coefficient of drug interaction) was calculated as CDI = AB / (A × B), A, B and AB are
the ratios of the treatments to control. Synergistic effect was indicated with CDI > 1 (Xu
et al., 2007).
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RESULTS

Inhibition of PARP activity by different PAHs in primary mouse thymus cells
As a control for PARP inhibition studies in murine thymocytes, we examined the
direct effects of PAH on PARP activity following in vitro exposures. Thymus cells
harvested from male C57BL6J mice were treated with 100 nM BaP, BeP, 3-MC, DMBA,
DAC, DAH, DMA, ANTH, BA, DBC, BP-diol, BPDE, DMBA-diol or DBC-diol for 18
h in vitro. As shown in Figure 5.1, PARP activity was inhibited by 3-MC, DMBA, DAC,
DAH, DBC, BPDE, DMBA-diol and DBC-diol, while BaP, BeP, DMA, ANTH, BA and
BP-diol did not cause PARP inhibition. The mechanism of differential inhibition of
PARP activity by PAHs was not determined in this study. Cell recoveries and viabilities
after the exposure to PAHs are listed in Table 5.1. Based on this PARP screening, it
appeared that BaP, BP-diol, and BPDE were good candidates for examining interactions
with As+3 based on their relative lack of direct PARP inhibition and their environmental
relevance.
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Figure 5.1. PARP activity in primary mouse thymus cells treated with PAHs in vitro.
Primary thymus cells isolated from C57BL/6J male mice were exposed to different PAHs
at 100 nM for 18 h in vitro. PARP activity was measured using Trevigen ELISA kits.
*Significantly different compared to control (p<0.05). Results are Means ± SD.

117

Table 5.1. Cell recovery and viability of 2 x 106 (Viability at plating: 88.7%) of primary
thymus cells following exposure to different PAHs at 100 nM in vitro for 18 h; Viability
was measured by AO/PI staining and Cellometer1.
Treatments (100 nM)

Cell Counts (106 cells)

Viability (%)

Control (no treatment)

1.84 ± 0.07

84.2 ± 1.1

BaP

1.89 ± 0.11

83.5 ± 0.8

BeP

1.81 ± 0.12

82.9 ± 1.2

3-MC

1.77 ± 0.09

81.4 ± 1.1*

DMBA

1.78 ± 0.15

80.9 ± 1.2*

DAC

1.76 ± 0.09

83.2 ± 1.3

DAH

1.75 ± 0.14

82.7 ± 1.1

DMA

1.76 ± 0.11

84.1 ± 0.9

ANTH

1.81 ± 0.03

84.5 ± 0.8

BA

1.83 ± 0.09

82.9 ± 1.1

DBC

1.55 ± 0.08*

79.9 ± 1.7*

BP-diol

1.75 ± 0.13

83.2 ± 0.9

BPDE

1.60 ± 0.05*

78.9 ± 1.2*

DMBA-diol

1.69 ± 0.08

80.1 ± 0.8*

DBC-diol

1.43 ± 0.12*

72.6 ± 1.5*

1

Triplicate samples were analyzed for each PAH treatment. Results are Means ± SD.
*Significantly different from Cont (p<0.5)
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Interactive genotoxicity induced by low concentrations of As+3 and BP-diol/BPDE
In order to examine the interactions between BaP/BP-diol/BPDE and As+3,
primary thymus cells were treated in vitro with 100 nM BaP, BP-diol or BPDE, 5 or 50
nM As+3 and in combinations for 18 h. A Comet assay was used to detect the DNA
damage induced by different treatments. A synergistic increase in DNA damage was
observed with the combined treatments of 5 nM As+3 + 100 nM BP-diol and 50 nM As+3
+ 100 nM BPDE (Fig. 5.2A). A significant decrease in PARP activity was also seen with
the same treatments (Fig. 5.2B). Thus, As+3 at very low concentrations interacts with BPdiol and BPDE leading to inhibition of PARP and to a synergistic increase in DNA
damage. However, since BaP, did not cause an interactive effect with As+3, the two
metabolites, BP-diol and BPDE we focused on these PAHs in the subsequent studies.
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Figure 5.2. DNA damage and PARP activity in primary thymus cells treated with As+3,
BaP/BP-diol/BPDE and the combinations in vitro. Primary thymus cells isolated from
C57BL/6J male mice were exposed to 5 or 50 nM As+3, 100 nM BaP, BP-diol or BPDE
and the combinations of As+3 and BaP/BP-diol/BPDE for 18 h in vitro. A, Comet assay
images were scored by CometScore. B, PARP activity measured with Trevigen ELISA
kits represented by absorbance at 450 nm. *Significantly different compared to control
(p<0.05). # Synergistic effect compared to 5 nM As+3 and 100 nM BP-diol (CDI > 1).
$ Synergistic effect compared to 50 nM As+3 and 100 nM BPDE (CDI > 1). Results are
Means ± SD.
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Co-exposure to As+3 and BP-diol/BPDE induced apoptosis in thymus cells
Annexin V staining and flow cytometry were used to see if the interactive
genotoxicity induced by the combined treatments caused an increase in apoptosis.
Primary thymus cells were treated with 5 or 50 nM As+3, 100 nM BP-diol or BPDE, and
their combinations in vitro for 18 h. A decrease in Annexin V-positive and PI-negative
cells (e.g. viable cells), and an increase in Annexin V-positive cells (e.g. early and late
apoptotic cells) was seen with treatments of 5 nM As+3 + 100 nM BP-diol and 50 nM
As+3 + 100 nM BPDE (Fig. 5.3A and 5.3B). Again, an apparent effect was observed with
combination treatments, as neither As+3 or BP-diol cause any decrease in viability when
present as single agents. The increase in the percentage of apoptotic cells was correlated
with the decrease of cell viability (Fig. 3A and 3C). Therefore, the co-exposure of low
concentrations of As+3 and BaP metabolites not only induced significant genotoxicity, but
also caused cell apoptosis in primary thymus cells.
Co-exposure to As+3 and BP-diol/BPDE did not induce superoxide production in
thymus cells
In order to see if the interactive effects observed were caused by an induction of
reactive oxygen species (ROS), primary thymus cells were treated with 5 or 50 nM As+3,
100 nM BP-diol or BPDE, and their combinations in vitro for 18 h. DHE staining by flow
cytometry was performed to see the superoxide levels in these treatments. As there was
no significant change in superoxide production in these treatments (Fig. 5.4), the
interactive effects observed in As+3 and BP-diol/BPDE combined treatments were not
caused by superoxide production.
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Figure 5.3. Annexin V and Propidium Iodide staining in primary thymus cells treated
with As+3, BP-diol/BPDE and the combinations in vitro. Primary thymus cells isolated
from C57BL/6J male mice were exposed to 5 or 50 nM As+3, 100 nM BP-diol or BPDE
and the combinations of As+3 and BP-diol/BPDE for 18 h in vitro. A. flow cytometry
results showing cells which are Annexin V-PI- (LL), Annexin V+PI- (LR), Annexin VPI+ (UL), or Annexin V+PI+ (UR). B, viability (% of Annexin V-PI- cells). C. % of early
and late apoptotic cells (% of Annexin V+ cells). *Significantly different compared to
control (p<0.05). # Synergistic effect compared to 5 nM As+3 and 100 nM BP-diol
(CDI > 1). $ Synergistic effect compared to 50 nM As+3 and 100 nM BPDE (CDI > 1).
Results are Means ± SD.
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Figure 5.4. . DHE staining in primary thymus cells treated with As+3, BP-diol/BPDE and
the combinations in vitro. Primary thymus cells isolated from C57BL/6J male mice were
exposed to 5 or 50 nM As+3, 100 nM BP-diol or BPDE and the combinations for 18 h in
vitro. A, flow cytometry results showing unstained cells and positive control (100 μM
H2O2 for 10 min). B, DHE mean channel fluorescence.
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Interactive effects on DNA damage were induced by As+3 direct PARP inhibition
To further test our hypothesis that As+3 induced interactive genotoxicity with BPdiol/BPDE by PARP inhibition, we utilized a potent specific PARP inhibitor, DPQ (Suto
et al., 1991), to treat primary thymus cells together with BP-diol/BPDE in vitro for 18 h.
A significant increase in DNA damage was observed in cells treated with 1 μM DPQ +
100 nM BP-diol and 1 μM DPQ + 100 nM BPDE (Fig. 5.5), indicating that PARP
inhibition is associated with a synergistic increase in DNA damage produced by BPdiol/BPDE.
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Figure 5.5. DNA damage in primary thymus cells treated with DPQ (a known PARP
inhibitor), BP-diol/BPDE and the combinations in vitro for 18 h. Primary thymus cells
isolated from C57BL/6J male mice were exposed to 1 μM DPQ, 100 nM BP-diol or
BPDE and the combinations for 18 h in vitro. DNA damage was measured by percentage
of DNA in tail using alkaline Comet assay *Significantly different compared to control
(p<0.05). # Synergistic effect compared to 1 μM DPQ and 100 nM BP-diol (CDI > 1).
$ Synergistic effect compared to 1 μM DPQ and 100 nM BPDE (CDI > 1). Results are
Means ± SD.
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CYP1A1 and CYP1B1 RNA expressions and activities were altered by As+3 and BPdiol/BPDE co-exposures
The metabolism of BaP and BP-diol is dependent on CYP1A1 and CYP1B1. In
order to see if the co-exposures might affect the metabolism of BaP, primary thymus cells
were treated with As+3, BP-diol/BPDE and the combinations for 18 h in vitro. Expression
of CYP1A1 and CYP1B1 was analyzed by qPCR. We found that As+3 increased the
expression of CYP1A1 and CYP1B1 only when combined with BP-diol (Fig. 6A and
6B). Interestingly, BPDE (100 nM) decreased the expression of CYP1A1 and CYP1B1
when combined with 50 nM As+3 (Fig. 5.6A and 5.6B). The induction of CYP1A1 and
CYP1B1 suggests that As+3 may also increase BPDE adduct formation by BP-diol
through enzyme induction, which is also supported by a trend of increase of BPDE
adduct formation measured by a chemiluminescence immunoassay in As+3 and BP-diol
18 h co-treatment. In order to confirm the activities of CYP1A1 and CYP1B1 were
altered by these combined treatments, a luminescent CYP1A1/1B1 activity assay was
performed using a prolyciferin CYP1A1/1B1 common substrate-Luciferin-CEE. Again,
significant increase of CYP1A1/1B1 activity was observed in 5 nM As+3 and 100 nM BPdiol combined treatments, and 50 nM As+3 + 100 nM BPDE decreased the activity (Fig.
5.7), indicating the alteration of CYP1A1 and CYP1B1 mRNA expression did affect their
activities.
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Figure 5.6. mRNA expression of CYP1A1 and CYP1B1 in primary thymus cells treated
with As+3, BP-diol/BPDE and the combinations in vitro. Primary thymus cells isolated
from C57BL/6J male mice were exposed to 5 or 50 nM As+3, 100 nM BP-diol or BPDE
and the combinations of As+3 and BP-diol/BPDE for 18 h in vitro. Expression of
CYP1A1 and CYP1B1 were examined by RT-qPCR. A, CYP1A1 expression. B,
CYP1B1 expression. *Significantly different compared to control (p<0.05). # Synergistic
effect compared to 5 nM As+3 and 100 nM BP-diol (CDI > 1). $ Synergistic effect
compared to 50 nM As+3 and 100 nM BPDE (CDI > 1). Results are Means ± SD.
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Figure 5.7. CYP1A1/1B1 activities in primary thymus cells treated with As+3, BPdiol/BPDE and the combinations in vitro. Primary thymus cells isolated from C57BL/6J
male mice were exposed to 5 or 50 nM As+3, 100 nM BP-diol or BPDE and the
combinations of As+3 and BP-diol/BPDE for 18 h in vitro. CYP1A1/1B1 activities were
examined using a Luciferin substrate. After 3 h incubation, the Luciferin substrate was
added and luminescence was measured. Data was presented as % of changes in
luminescence compared to Cont. *Significantly different compared to control (p<0.05).
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DISCUSSION

Environmental exposures to As+3 and PAHs such as BaP are common and are
known to produce adverse health effects in millions of people throughout the world. The
interactions between these chemicals and related family members have not been well
studied. BaP and its metabolites are known to cause DNA damage through DNA adduct
formation that induce strand breaks (Hockley et al., 2007). Our previous reports indicated
that As+3 induces genotoxicity in mouse primary thymus cells at environmentally relevant
levels through PARP inhibition associated with DNA repair which may lead to
immunotoxicity (Xu et al., 2016). Since many people are co-exposed to PAHs and
arsenic, it is important to understand their potential mechanism(s) of interaction.
Previous studies on the interactions between BaP and As+3 have shown that As+3
potentiates BaP toxicity (Lewińska et al., 2007; Maier et al., 2002). However, these
studies were conducted at high concentrations that exceeded those expected to result from
environmental exposures. Our previous studies demonstrated that DBC is a strong
immunosuppressant of murine spleen cells (Lauer et al, 2015), and that As+3 interacts
with DBC at extremely low concentrations to suppress mouse bone marrow pre-B cells
(Ezeh et al., 2015). In the present study, the interactions between As+3 and the
metabolites of BaP on genotoxicity in mouse thymus cells were analyzed within the
nanomolar range of exposure, which are more representative of environmental exposures.
PARP is the initiator of base excision repair of DNA damage. Inhibition of PARP
is known to cause DNA damage during cell replication (Dale Rein et al., 2015). Based
on our previous findings on genotoxicity of arsenic and PAHs (Harper et al., 2015; Li et
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al., 2010; Xu et al., 2016 ), we proposed that As+3 potentiates the DNA damage induced
by PAHs through PARP inhibition. Our preliminary experiments revealed that certain
PAHs did not interact with low concentrations of As+3, which might have been due to
their ability to inhibit PARP activity on their own (data not shown). Therefore, we
screened different PAHs for their ability to inhibit PARP, and the results indicated that
some PAHs (such as DBC, 3-MC, DMBA, and DAC) can inhibit PARP activity (Fig.
5.1). We selected the BaP family in subsequent studies based on the lack of PARP
inhibition by its two metabolites (BP-diol and BPDE) and their environmental relevance.
The inhibition of PARP by DBC, 3-MC, DAC and DMBA confounds the ability to see
their interactive effects based on DNA damage alone. We did not investigate the
mechanism(s) of inhibition of PARP by these PAHs in the present study. Further
mechanistic studies need to be conducted in order to form a complete picture of the
genotoxicity induced by certain PAHs and their potential interactions with As+3.
CYP1A1 and CYP1B1 are essential for the metabolism of BaP and BP-diol to
BPDE. Previous studies on the effect of arsenic on CYP1A1 and CYP1B1 expression
have yield mixed results. Some studies showed that As+3 diminished CYP1A1 and
CYP1B1 induction in breast cancer cells in vitro (Spink et al., 2002), while others
revealed that As+3 could increase their expression by AhR induction in lung cells after in
vivo exposure (Wu et al., 2009). In our study, we showed differential effects of As+3 +
BP-diol and As+3 + BPDE (Fig. 5.6A and 5.6B). It is very interesting that As+3
potentiated CYP1A1 and CYP1B1 expression following the co-treatment with 100 nM
BP-diol at 5 nM As+3. BP-diol is known to be an agonist of the AhR (Chen et al., 2003),
but the mechanism by which As+3 increases CYP1A1 and CYP1B1 in thymus cells is
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unknown and needs to be identified in future studies. Also, we found a trend of increase
in BPDE adduct formation in thymus cells treated with low concentrations of As+3 and
BP-diol (Supplementary Fig. 1), using a highly sensitive chemiluminescence
immunoassay (Divi, et al., 2002). Therefore, it is likely that low concentrations of As+3
induce interactive genotoxicity with BP-diol not only by inhibiting DNA repair, but also
by increasing the formation of DNA adducts resulting from the conversion of BP-diol to
BPDE.
The decrease in expression of CYP1A1 and CYP1B1 that occurred following cotreatments with As+3 and BPDE may be the result of apoptosis. We found that low
concentrations of As+3 and BP-diol/BPDE produced apoptosis following co-treatments,
which correlated with an increase in DNA damage (Fig. 5.2A and 5.3A). The
concentrations of As+3 and BP-diol/BPDE used in our study were very low and had
limited cytotoxicity on their own. However, the fact that As+3 and BP-diol/BPDE cotreatments induced significant apoptosis in primary thymus cells at such low
concentrations is significant.
In summary, As+3 potentiates the DNA damage induced by the metabolites of BaP
at environmentally relevant concentrations through PARP inhibition. Interactive
genotoxicity and apoptosis were observed at low concentrations of As+3 in combination
with BP-diol/BPDE. The induction of CYP1A1 and CYP1B1 expression by As+3 and BPdiol may play a partial role in the synergistic genotoxicity found in these studies. These
findings show that As+3 and certain PAHs may interact with thymus cells at extremely
low concentrations. These interactions should be considered in the assessment of risk
associated with human exposures.
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ABSTRACT

Arsenite (As+3) exposure is known to cause immunotoxicity in human and animal
models. Our previous studies demonstrated that As+3 at low concentrations induced both
genotoxicity and non-genotoxicity in mouse thymus cells. Developing T cells at CD4CD8- double negative (DN) stage, the first stage after early T cells are transported from
bone marrow to thymus, were found to be more sensitive to As+3 toxicity than the T cells
at CD4+CD8+ double positive (DP) stage in vitro. Induction of Mdr1 (Abcb1) and Mrp1
(Abcc1), two multidrug resistance transporters and exporters of As+3, was also associate
with the reversal of As+3 induced double strand breaks and DNA damage. In order to
confirm the differential sensitivities of thymic cell populations to As+3 in vivo, male
C57BL/6J mice were exposed to 0, 100 and 500 ppb As+3 in drinking water for 30 d. A
significant decrease in DN cell percentage was observed with exposure to 500 ppb As+3.
Low concentrations of As+3 were also shown to induce higher genotoxicity in sorted DN
cells than DP cells in vitro. Calcein AM uptake and Mdr1/Mrp1 mRNA quantification
results revealed that DN cells not only had limited As+3 exporter activity, but also lacked
the ability to activate these exporters with As+3 treatments, resulting in a higher
accumulation of intracellular As+3. Knockdown study of As+3 exporters in the DN thymic
cell line, D1 using siRNA, demonstrated that Mdr1 and Mrp1 regulate intracellular As+3
accumulation and genotoxicity. Taken together, the results indicate that transporter
regulation is an important mechanism for differential genotoxicity induced by As+3 in
thymocytes at different developmental stages.
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INTRODUCTION

Arsenic (As) contamination of food and drinking water affects millions of people
world-wide. Arsenite (As+3) is a prevalent trivalent inorganic form of As in the
environment. As+3 exposure has been associated with multiple diseases such as diabetes,
cardiovascular diseases and cancers (Argos et al., 2010; Schuhmacher-Wolz et al.,
2009;Vahter et al., 2008). The immunosuppression caused by As+3 exposure in humans
and animal models has been reported by multiple groups (Gonsebatt et al., 1994; SotoPena et al., 2006; Biswas, et al., 2008; Kozul et al., 2009). Many studies have
demonstrated that As+3 has detrimental effects on different types of immune cells (Ezeh
et al., 2015; 2016; Sakurai et al., 2006). The thymus is the primary immune organ for the
development of T cells, which are key in both humoral and the cell-mediated immunity.
During development in thymus, T cells undergo changes in surface marker expression
that allow us to recognize distinct subsets: double negative (CD4-CD8-, DN), double
positive (CD4+CD8+, DP) and single positive (CD4+ or CD8+, SP) (Germain, 2002).
Epidemiological studies have indicated that children exposed to low levels of As+3 in
utero have impaired thymic function and reduced numbers and types of peripheral T cells
(Ahmed et al., 2012).Thymic atrophy and cell cycle arrest have also been observed in
mice exposed to As+3 in vivo (Nohara et al., 2008; Schulz et al., 2002). These studies
highlight the necessity for gaining an understanding of the mechanisms of As+3 induced
toxicities in the thymus.
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Our previous studies have demonstrated that As+3 at environmentally relevant
concentrations can induce DNA damage in mouse thymus cells through the inhibition of
poly ADP ribose polymerase (PARP) activity as well as the generation of oxidative stress
(Xu et al., 2016d). PARP has a DNA binding domain that contains two zinc (Zn) fingers.
As+3 is known to cause functional impairment of PARP by replacing the Zn on the Zn
fingers (Qin et al., 2012; Sun et al., 2014; Zhou et al., 2011, 2014). Studies have indicated
that the dual actions of As+3 also include the induction of oxidative stress at higher
concentrations (Ding et al., 2009; Qin et al., 2008), which was confirmed in our mouse
thymic cell model in vitro at a 500 nM As+3 concentration (Xu et al., 2016d). Previous
studies in our laboratory have also demonstrated that immune cells are extremely
sensitive to As+3 treatments (Burchiel et al., 2014; Ezeh et al., 2014; Li et al., 2010; Xu et
al., 2016b). We have also described the differential sensitivities of mouse peripheral
lymphoid organs and tissues to As+3 (Xu et al., 2016c). Therefore, understanding the
mechanism of the differential sensitivity of different types of immune cells is important
for evaluating As+3 induced immunotoxicity.
As+3 enters cells via the aquaglyceroporins (AQP3, AQP7, AQP9, AQP10), the
glucose permeases (GLUT1, GLUT2, GLUT5), and the organic anion transporting
polypeptides (OATP1B1, OATP2B1) (Maciaszczyk-Dziubinska et al., 2012). Multidrug
resistance protein, Mdr1 (ABCB1, P-glycoprotein 1), and multidrug resistance-associated
proteins, Mrp1 (ABCC1) and Mrp2 (ABCC2), are the known exporters of As+3 in
eukaryotic cells. Many studies have indicated that the over-expression of Mdr1, Mrp1
and Mrp2 is responsible for As+3 resistance in certain type of cells (Liu et al., 2001; Liu
et al., 2002). In our previous studies, we demonstrated that up-regulation of Mdr1 and
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Mrp1 in a thymic T cell line, D1, decreased oxidative DNA damage (Xu et al., 2016d).
Therefore, these ATP binding cassette subfamily transporters may be the key factors that
regulate the toxicity induced by As+3.
Our previous studies demonstrated that DN cells are more prone to As+3 induced
toxicity than DP cells in vitro (Xu et al., 2016a). In the present study, the genotoxicity
induced of As+3 in DN and DP cells was analyzed and compared. We also examined
differences in the expression of As+3 exporters between DN and DP cells and studied the
roles of these exporters in the regulation of As+3 induced genotoxicity in thymus cells.
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MATERIALS AND METHODS

Chemicals and reagents
Sodium arsenite (CAS 774-46-5, Cat. No. S7400, Purity > 90%), Dulbecco’s
phosphate buffered saline w/o Ca+2 or Mg+2 (DPBS-), RPMI 1640 HEPES modified
medium , dimethylsulfoxide (DMSO, Cat. No. D2650) and β-Mecaptoethanol (2-ME,
Cat. No. M3148) were purchased from Sigma-Aldrich (St. Louis, MO). Hanks Balanced
Salt Solution (HBSS) was purchased from Lonza (Walkersville, MD). Fetal Bovine
Serum (FBS) was purchased from Atlanta Biologicals (Flowery Branch, GA).
CometAssay® 20 well ES starter kit (Cat. No. 4252-040-ESK) was purchased from
Trevigen (Gaithersburg, MD). RNeasy Mini Kit™ and QIAshredder™ were purchased
from Qiagen (Valencia, CA). Penicillin/Streptomycin 10,000 (U/ml and 10,000
(µg/mL)), 200 mM L-Glutamine, Dihydroethidium (DHE, Cat. No. D11347), high
capacity cDNA reverse transcription kit (Cat. No. 4368814), Gapdh (Mm99999915_g1),
Mdr1a (Mm00440761_m1), Mdr1b (Mm00440736_m1), Mrp1 (Mm00456156_m1),
Mrp2 (Mm00496899_m1), Nrf2 (Mm00477784_m1), Hmox1 (Mm00516005_m1)
TaqMan® gene expression assays and TaqMan® universal PCR master mix (Cat. No.
4304437) were purchased from Life Technologies (Grand Island, NY). Recombinant
murine IL-7 (Cat. No. 217-17) was purchased from Peprotech (Rocky Hill, NJ). Mdr1
(Cat. No. sc-35891), Mrp1 (Cat. No. sc-35961), scrambled negative control (Cat. No. sc37007) and FITC-conjugated positive control (Cat. No. sc-36869) siRNAs were
purchased from Santa Cruz Biotechnology (Dallas, TX). Accell siRNA delivery media
(Cat. No. B-005000-500) was purchased from Dharmacon (Lafayette, CO). FITC rat anti-
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mouse CD8a (Cat. No.553031), PE rat anti-mouse CD8 (Cat. No.553033), PE rat antimouse CD4 (Cat. No. 553730) and APC rat anti-mouse CD4 (Cat. No.553051) antibodies
were purchased from BD Biosciences (San Jose, CA). EasySep™ PE positive selection
kit (Cat. No. 18557) was purchased from STEMCELL Technologies (Cambridge, MA).
Cellometer staining solution, acridine orange/propidium iodide (AO/PI) staining (Cat.
No. CS2-0106-5ML) was purchased from Nexcelom Bioscience (Manchester, UK).
Calcein acetoxymethyl ester (Calcein AM, Cat. No.14948), Verapamil (Cat. No. 14288),
and MK-571 (Cat. No. 10029) were purchased from Cayman Chemical (Ann Arbor, MI).
Animal exposures and primary mouse thymus cells isolation
C57BL/6J male mice were purchased from Jackson Laboratory (Bar Harbor, ME)
at 8-10 weeks age. Experiments or treatments were performed after at least one week of
acclimation in our animal facility. All animal experiments were performed following the
protocols approved by the Institutional Animal Use and Care Committee at the University
of New Mexico Health Sciences Center. For in vivo experiments, 2-3 mice (5 per group)
were housed per cage and exposed to As+3 at 0 (control), 100 or 500 ppb via drinking
water for 30 d. Mice were fed with 2020X Teklad global soy protein-free extruded rodent
diet (Envigo, Indianapolis, IN) throughout the experiment. As+3 doses were prepared
fresh weekly by weighing each water bag and determining the appropriate amount of
As+3 stock to add to each bag. Water bags were weighed after each weekly collection and
the change in weight was used to estimate the amount of water consumed by mice in each
cage. Concentrations of As+3 in drinking water bags were verified using Mass
Spectrometry by Dr. Abdul-Mehdi S. Ali at Department of Earth and Planetary Sciences,
University of New Mexico. Mice were euthanized after 30 d exposure or on the day of in
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vitro experiment. Thymuses were harvested and transferred to the laboratory on ice in
HBSS on ice. Single cell suspensions of spleen and thymus cells were prepared by
homogenizing the organ between the frosted ends of two sterilized microscope slides
into a dish containing 5 mLof cold mouse medium (RPMI 1640 with 10% FBS, 2 mM Lglutamine, 100 units/mL penicillin and 100 µg/mL streptomycin). For in vitro
experiments, cell suspensions from 3 mice were pooled. Cells were then centrifuged at
200 x g for 10 min and resuspended in fresh mouse medium. Cell numbers and
viabilities were determined by AO/PI staining and counting using the Nexcelom
Cellometer 2000.
CD4, CD8 and DHE staining
DHE was resuspended with 158 µl DMSO and diluted to a final concentration of
5 µM with DPBS-. 1 x 106 cells were washed with DPBS-, resuspended in 100 µl of 5 µM
DHE solution and stained with 0.5 µg of APC-conjugated anti-CD4 and FITC-conjugated
anti-CD8 antibodies for 30 min in a 37 °C incubator. Cells were washed twice with
DPBS- before analysis on an AccuriC6 Flow Analyzer (BD Bioscences).
DN cell enrichment and cell sorting
In order to yield enough DN cells for our experiments, an aliquot of the isolated
thymus cells were concentrated to 1 x 108 cells/mL in mouse medium and stained with 2
μg/mL PE-conjugated anti-CD4 and PE-conjugated anti-CD8 antibodies for 15 min at
RT. 100 μl of PE selection cocktail was then added to 1 mL of cell suspension. After 15
min RT incubation, 50 μl of magnetic nanoparticles was added to the cell suspension and
mixed by pipetting followed by a 10 min incubation at RT. Then cell volumes were
brought up to 2.5 mL by adding DPBS- containing 2% FBS and 1 mM EDTA. Tubes
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were then placed into the magnet for 5 min and cells that remained in suspension (DN
cells) were collected into a fresh tube. Enriched DN cells and the remaining total thymus
cells were stained with 2 μg/mL FITC-conjugated anti-CD8 and APC-conjugated antiCD8 in mouse medium and DN and DP cells were sorted on an iCyt SY3200 cell sorter
(Sony, San Jose, CA) at 15,000 events/s to achieve >99% purity. The enrichment step
with magnetic nanoparticles increased the efficiency of getting DN cells by
approximately twenty times.
The single cell gel electrophoresis assay (Comet assay)
Cells were washed with DPBS- and resuspended at 1 x 106 cells/mL in DPBS-. 30
μl of cells were placed into a 1.5 mL microcentrifuge tube containing 250 μl low melting
point agarose at 37 °C and then each sample was applied to a one well of a 20-well
CometSlide™ (Trevigen). After the agarose was solidified, cells were lysed overnight
with Lysis Solution + 10% DMSOl The following day the slide was electrophoresed in
ice cold alkaline buffer with 1 mM EDTA (pH>13) at 21 volts for 30 min. Slides were
dried, stained with Sybr Gold and imaged with an Olympus IX70 inverted fluorescence
microscope. 50 cells from each well of the slides were scored using CometScore (TriTek
Corp., Sumerduck, VA).
Oxidation state specific Hydride Generation- Cryotrapping- Inductively Coupled
Plasma- Mass Spectrometry
The analysis of As species by HG-CT-ICP-MS was performed as previously
described (Currier et al., 2014; Matoušek et al., 2013). Briefly, cell pellets were lysed in
ice-cold deionized water. The trivalent species were measured in an aliquot of cell lysate
directly. Another aliquot was treated with 2% cysteine and analyzed for total inorganic
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As (As+3 and As+5), total methyl-As (MMA+3 and MMA+5), and total DMAs (DMA+3 and
DMA+5). Cysteine-treated pentavalent As standards were used for calibration as
previously described (Hernández-Zavala et al., 2008). The LODs for As species analyzed
by HG-CT-ICP-MS ranged from 0.04 pg As for methylated arsenicals to 2.0 pg As for
inorganic arsenicals. All values were expressed as pg of As in an arsenic species.
RNA isolation and qPCR
RNA isolation was performed on mouse thymus cells following the manual of the
RNeasy Mini Kit ™ and QIAshredder™ from the manufacturer. An Agilent Nanodrop
spectrophotometer (Santa Clara, CA) was used to quantify the concentrations of extracted
RNA in each sample. 60 µl mixed solution containing a minimum of 1080 ng RNA was
reverse transcribed (RT reaction) on SimpiAmps thermal cycler (Life Technologies)
using the high capacity cDNA reverse transcription kit. Samples were then diluted to ~6
ng/ µl with RNase, DNase free water and stored at -20 °C. Real time PCR (qPCR)
reactions were performed in 10 μl per reaction in a 384-well plate with TaqMan® gene
expression assays of GAPDH, Mdr1a, Mdr1b, Mrp1, Mrp2, Nrf2 and Hmox1 probes on a
Applied Biosystems ViiA™ 7 Real-Time PCR System (Life Technologies). Comparative
CT (first amplification cycle exceeding threshold) was applied for quantification, and
GADPH was used as the endogenous control. The method to calculate the comparative
CT is described in detail in the manual from Life Technologies.
Calcein AM uptakessay
The calcein AM assay was performed according to the uptake assay procedures
previously described (Bircsak et al., 2013; Olson et al., 2001; Udasin et al., 2016).
Briefly, calcein AM was added into 1 x 106 mouse thymus cells in 1 mL of 37 °C pre-
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warmed mouse medium to a final concentration of 50 nM. Samples were incubated at 37
°C in the dark for 30 min with or without 20 μM Verapamil (Mdr1 inhibitor) or 50 μM
MK-571 (Mrps inhibitor). For cell subset differentiation, cells were then washed and
resuspended in 100 μl cold DPBS- , stained with 0.5 µg of APC-conjugated anti-CD4 and
PE-conjugated anti-CD8 antibody for 30 min on ice in the dark. After two washes with
cold DPBS-, cells were analyzed on an AccuriC6 Flow Analyzer (BD Bioscences).
Mdr1, Mrp1 siRNA knockdown in D1 cells
The D1 cell line was a gift from Dr. Scott K. Durum (Center for Cancer Research,
NIH, Frederick, MD). The D1 cell line is a CD4-CD8-, IL-7 dependent early T cell line
established from p53 knockout mouse thymocytes (Kim et al., 2003). As previously
described, cells were maintained in mouse medium with 55 µM 2-ME and 50 ng/mL IL-7
and sub-cultured every three days (Xu et al., 2016a). For siRNA knockdown experiments,
D1 cells were resuspended in siRNA delivery medium (Accell siRNA delivery media +
2% FBS + 50 ng/mL IL-7) at 2 x 105 cells/mL with mouse Mrp1, mouse Mdr1,
scrambled or FITC-labeled scrambled control siRNA at 20 nM concentration and
incubated in 37 °C, 5% CO2 humidified incubator for 52 h as previously described
(Ruppert et al., 2012). Cells were then re-plated into a 6 well plate in mouse medium with
55 µM 2-ME and 50 ng/mL IL-7, treated with As+3 at 50 and 500 nM concentrations for
18 h.
Statistics
Excel 2010 and Sigma Plot 12.5 software were used for data analysis. One-way
analysis of variance (ANOVA) followed by a Dunnett’s Method (multiple comparisons
versus control group) were used to determine differences between control and treatment
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groups. For the in vivo As+3 experiments, 5 animals (n=5) were assigned to each group.
Three independent experiments were conducted and comparable results were acquired.
For the in vitro experiments, three replicates were performed and analyzed for each dose.
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RESULTS

Selective toxicity in DN cells population after in vivo As+3 exposure
Previous studies in our lab demonstrated As+3 treatments selectively decreased
DN cell percentage in vitro (Xu et al., 2016a). In order to see whether DN cells are more
sensitive to As+3 in vivo, 9-week old male C57BL/6J mice were exposed to 0, 100 and
500 ppb As+3 for 30 d via drinking water. Thymus cells were isolated and stained with
CD4 and CD8 cell surface markers and analyzed on a flow cytometer. A significant
decrease in DN cell percentage was observed at 500 ppb (Fig. 6.1A). There was no
change in DP cell percentage (Fig. 6.1B). We also calculated the total cell number of
each population using the total thymus cell recovery from each individual mouse to
determine if the absolute cell numbers in the DN and DP populations were affected.
Although significant decreases in total cell numbers were observed in both DN and DP
cells (Fig. 6.1C and 6.1D), the decrease in DN cells was higher than in DP cells. These
results indicated that As+3 exposure in vivo selectively reduced DN cell percentage,
which resulted in an overall decrease of the cell numbers at later stage.
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Figure 6.1. DN and DP percentage of cells and cell numbers from 30 d As+3 drinking
water-exposed mice. 9-week old male C57BL/6J mice were exposed to 0, 100 and 500
ppb As+3 through drinking water for 30 d. Thymus cells were isolated, stained with CD4
and CD8 surface markers, and analyzed on a flow cytometer. A, % of DN cells in thymus
cells. B, % of DP cells in thymus cells. C, total DN cell numbers (% of DN cells x total
cell recovery). D, total DP cell numbers (% of DP cells x total cell recovery). *
Significantly different compared to control (p<0.05, n=5). Results are Means ± SD.
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DN cells were more sensitive to As+3 induced genotoxicity and oxidative stress than
DP cells in vitro
The selective reduction of DN cell percentage was observed both in vitro and in
vivo. In order to see if As+3 induces higher genotoxicity in DN cells than DP cells,
primary thymus cells from four12-week old male C57BL/6J mice were isolated, pooled
and sorted into the DN and DP cell populations (Fig. 6.2A). DN, DP and un-sorted
thymus cells were treated with 0 (control), 50 and 500 nM As+3 for 18 h in vitro. Cell
viability was examined using AO/PI staining, and DNA damage was analyzed by Comet
assay. A significant decrease in cell viability was only observed at 500 nM As+3
treatment for DN cells (Fig. 6.2B). A dose-dependent increase of DNA damage was
observed in DN cells starting at 50 nM (Fig. 6.2C), indicating that DN cells are more
prone to As+3 induced DNA damage. Oxidative stress in sorted DN and DP cells was
measured by DHE staining on a flow cytometer and Hmox1 mRNA expression by qPCR.
Dose-dependent increases in both DHE fluorescence and Hmox1 expression were
observed in DN cells after 18 h in vitro treatments with As+3(Fig 6.3A and 6.3B), which
was more significant than in DP cells. The expression of Nrf2, the oxidative stress
regulator, was also analyzed by qPCR. Up-regulation of Nrf2 was observed in both DN
and DP cells only at 500 nM (Fig. 6.3C).
Previous studies in our lab indicated that higher genotoxicity was associated with
greater intracellular As (Xu et al., 2016c). Therefore, we used HG- CT- ICP- MS system
to determine the intracellular As+3 accumulation in DN and DP cells after in vitro
treatments. More intracellular As+3 was observed in DN cells than DP cells with 18 h
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treatments of 50 and 500 nM As+3 (Fig. 6.4), suggesting that the selective genotoxicity in
DN cells may be the result of higher intracellular As+3 accumulation.
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Figure 6.2. Viability and DNA damage in DN and DP cells after 18 h in vitro treatments
with As+3. Thymus cells were isolated from three 12-14 week old male C57BL/6J mice
and pooled. Cells were enriched with STEMCELL EasySep™ PE positive selection kit,
stained with CD4 and CD8 surface markers and sorted into DN and DP cell populations.
Sorted cells were treated with 50 and 500 nM As+3 for 18 h in vitro. A, thymus cells were
sorted into DN and DP cells. B, cell viability were measured by AO/PI staining. C, DNA
damage was measured by alkaline Comet assay. * Significantly different compared to
control (p<0.05). Results are Means ± SD.
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Figure 6.3. Oxidative stress in DN and DP cells treated with As+3 for 18 h in vitro.
Thymus cells were isolated from three 12-14 week old male C57BL/6J mice, pooled,
sorted into DN and DP populations and treated with 50 or 500 nM of As+3 for 18 h. A,
superoxide production was measured by DHE mean channel fluorescence. B, Hmox1
mRNA expression was measured by qPCR. C, Nrf mRNA expression was measured by
qPCR. * Significantly different compared to control (p<0.05). Results are Means ± SD.
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Figure 6.4. Intracellular As+3 concentrations in DN and DP cells treated with As+3 in
vitro for 18 h. Thymus cells were isolated from three 12-14 week old male C57BL/6J
mice, pooled, sorted into DN and DP populations and treated with 50 or 500 nM of As+3
for 18 h. Intracellular As+3 accumulation was measured by HG-CT-ICP-MS. ND, not
detected. * Significantly different compared to control (p<0.05). # Significantly different
compared to the relative dose in DN cells (p<0.05). Results are Means ± SD.
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As+3 exporter mRNA expressions and activities in DN and DP cells after in vitro As+3
treatments
Mdr1 and Mrp1 are the exporters of As+3 in eukaryotic cells. Previous findings in
our lab suggested that the up-regulation of Mdr1 and Mrp1 in mouse thymus cells treated
with 500 nM As+3 decreased the oxidative stress and double strand breaks (Xu et al.,
2016d). To examine whether the DN and DP cells have differential Mdr1 and Mrp1
expressions, sorted DN and DP cells were treated with 0, 50, and 500 nM As+3 for 18 h in
vitro. Mdr1 (a and b) and Mrp1 expressions were analyzed by qPCR. Significant increase
of Mrp1 expression was observed in DP cells starting from 50 nM (Fig. 6.5C). Although
there was no significant increase in both Mdr1a and Mdr1b expression in DP cells, a
slight decrease in both Mdr1a and Mdr1b expression was observed in DN cells at 500 nM
(Fig. 6.5A and 6.5B). We also performed qPCR analysis on Mrp2 and did not see any
amplification, indicating that Mrp2 is not expressed in early T cells (data not shown).
These results suggested that DN and DP cells express different levels of the two As+3
exporters, especially with the treatments of As+3.
The Calcein AM assay has been used to measure Mdr1 and Mrp1 activities
(Evseenko et al., 2006; Oslon et al., 2001). We used the Calcein AM uptake assay to
compare exporter activities in DN and DP cells and optimized the staining concentration
to make it compatible with the surface marker staining. The Calcein mean channel
fluorescence was higher in DN cells than in DP cells with or without As+3 treatment,
suggesting that DN cells have lower exporter activities in general (Fig. 6.6). Treatment
with 500 nM As+3 for 18 h significantly increased calcein fluorescence in DN cells and
decreased calcein fluorescence in DP cells (Fig. 6.6B), indicating the differential patterns
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of exporter activation in DN and DP cells with As+3 treatments. Overall, these results
supported our hypothesis that Mdr1 and Mrp1 expressions and activations are different in
DN and DP cells, which may be the reason for differential sensitivities to As+3 induced
genotoxicity in the DN and DP cells.
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Figure 6.5. Mdr1a, Mdr1b and Mrp1 mRNA expression in DN and DP cells treated with
As+3 in vitro for 18 h. Thymus cells were isolated from three 12-14 week old male
C57BL/6J mice, pooled, sorted into DN and DP populations and treated with 50 or 500
nM of As+3 for 18 h. A, Mdr1a mRNA expression was measured by qPCR. B, Mdr1b
mRNA expression was measured by qPCR. C. Mrp1 mRNA expression was measured
by qPCR. *Significantly different compared to control (p<0.05). # Significantly different
compared to the relative dose in DN cells (p<0.05). Results are Means ± SD.

155

Figure 6.6. Calcein AM uptake in DN and DP cells treated with As+3 in vitro for 18 h.
Thymus cells were isolated from three 12-14 week old male C57BL/6J mice, pooled, and
treated 500 nM As+3. Calcein AM uptake assay was used to measure the activity of
exporters in DN and DP cells separated by CD4 and CD8 surface marker staining. A,
Histogram of unstained and calcein stained cells. B, Calcein mean channel fluorescence
in DN and DP cells after As+3 treatments. *Significantly different compared to control
(p<0.05). # Significantly different compared to the relative dose in DN cells (p<0.05).
Results are Means ± SD.
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Knockdown of Mdr1 and Mrp1 increased As+3 induced genotoxicity in vitro
A mouse thymic DN T cell line, D1, was utilized to confirm whether the
decreases in Mdr1 or Mrp1 expression affect the genotoxicity. D1 cells were cultured in
siRNA delivery medium with Mdr1 or Mrp1 siRNA and the successful delivery of
siRNA was confirmed (Fig. 6.7A). Significant increases calcein fluorescence was
observed with both Mdr1 and Mrp1 siRNA knockdown (Fig 6.7B), indicating a
suppression of exporter functions. Cells were also treated with As+3 for 18 h in vitro.
Significant increase of intracellular As+3 was observed in both knockdowns (Fig. 6.7C),
and there was no methylated forms of As in these cells. Interestingly, Mrp1 knockdown
increased the intracellular As+3 accumulation more significantly than Mdr1 knockdown.
These results suggested that the successful delivery of the siRNAs decreased the
activities of exporters and lead to increased intracellular As+3 accumulation in D1 cells.
The siRNA knockdown of Mdr1 and Mrp1 at mRNA levels was analyzed by
qPCR. A significant decrease in Mdr1 and Mrp1 mRNA expression was observed with
Mdr1 and Mrp1 siRNA, and Mrp1 siRNA achieved a higher percentage of knockdown
than Mdr1 siRNA (Fig. 6.8A, 6.8B and 6.8C). The knockdowns also confirmed the
activation of both genes by As+3 treatments. Interestingly, a slight increase in Mrp1
expression was observed with the knockdown of Mdr1 (Fig. 6.8A and 6.8B). Hmox1 was
also analyzed by qPCR in the siRNA knockdown samples and Mrp1 showed a much
higher increase in Hmox1 expression than Mdr1 with As+3 treatments. These results were
in agreement with the increase of intracellular As+3 levels after the siRNA knockdown
(Fig. 6.7C).
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The effects of the Mdr1 and Mrp1 knockdowns in D1 cells on viability and
DNA damage induced by As+3 were also examined. Decrease in cell viabilities and
increase in DNA damage were observed in Mdr1 and Mrp1 knockdowns (Fig. 6.9). Mrp1
siRNA knockdown had stronger effects on viability and DNA damage than Mdr1 siRNA
knockdown, which correlated with the intracellular As+3 accumulation (Fig. 6.7C).
Collectively, these results indicate that differences in Mdr1 and Mrp1 expression and
activity could result in differential cellular sensitivities to As+3 induced genotoxicity.
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Figure 6.7. Mdr1 and Mrp1 siRNA knockdowns in D1 cells. D1 cells were cultured in
Dharmacon Accell siRNA delivery system with Mdr1 and Mrp1 siRNAs for 52 h and
treated with As+3 for 18 h. siRNA-A was a scrambled siRNA as a control for delivery. A,
flow cytometry result to compare FITC fluorescence of siRNA-A with/without FITC
label after 52 h of culture in delivery medium. B, calcein fluorescence in D1 cells
transfected with Mdr1, Mrp1 siRNAs and siRNA-A. C, As+3 accumulation in D1 cells
transfected with Mdr1, Mrp1 siRNAs and siRNA-A. *Significantly different compared to
no siRNA or siRNA-A (p<0.05). Results are Means ± SD.
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Figure 6.8. Mdr1a, Mdr1b, Mrp1 and Hmox1 mRNA expression in D1 cells transfected
with Mdr1 and Mrp1 siRNA and treated with As+3 in vitro for 18 h. D1 cells were
transfected with Mdr1, Mrp1 siRNAs or siRNA-A. Transfected cells were then treated
with As+3 for 18 h and mRNA expressions were measured by qPCR. A, Mdr1a mRNA
expression. B, Mdr1b mRNA expression. C, Mrp1 mRNA expression. D, Hmox1 mRNA
expression. *Significantly different compared to Control (p<0.05), # Significantly
different compared to the relative dose in no siRNA (p<0.05). Results are Means ± SD.
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Figure 6.9. Viability and DNA damage in D1 cells after 18 h in vitro treatment with As+3
in Mdr1 and Mrp1 knockdowns. D1 cells were transfected with Mdr1, Mrp1 siRNAs or
siRNA-A. Transfected cells were then treated with As+3 for 18 h. A, cell viability were
measured by AO/PI staining. B, DNA damage was measured by alkaline Comet assay.
*Significantly different compared to Control (p<0.05). # Significantly different compared
to the relative dose in no siRNA (p<0.05). Results are Means ± SD.
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DISCUSSION

As+3 is known to cause detrimental effects on multiple types of cells and systems
(Argos et al., 2010; Biswas et al., 2008; Gonsebatt et al., 1994; Cooper et al., 2009; 2013;
Soto-Peña et al., 2006). Our previous results demonstrated that As+3 induced both
genotoxicity and non-genotoxicity in mouse thymus cells (Xu et al., 2016a; 2016d).
Although immune cells in general have high sensitivities to As+3, the early T cells at DN
stage were shown to be selectively targeted by low concentrations of As+3 in vitro (Xu et
al., 2016a). In this study, we confirmed that the selective decrease of DN cells also
occurred in mice exposed to As+3 via drinking water. The percentage of the DN cells, but
not the DP cells, was decreased in 500 ppb As+3 exposed mice (Fig. 6.1A and 6.1B). The
absolute DN and DP cell numbers were also decreased in 500 ppb As+3 exposed mice
(Fig 6.1C and 6.1D), indicating that the As+3 effects on cells at early stage resulted in a
decrease in later stage cell numbers. The study suggested that the reduction of thymus
cell number in 500 ppb As+3 exposed mice was the result of the selective toxicity on early
DN cells.
Mdr1, Mrp1 and Mrp2 are important As+3 efflux proteins in eukaryotic cells.
While Mrp2 is mainly expressed by hepatocytes, Mdr1 and Mrp1 are known to be
expressed in human immune cells (Jedlitschky et al., 2006; van der Kolk et al., 2001).
Our previous study demonstrated the induction of Mdr1 and Mrp1, which correlated with
the decreases of As+3, induced oxidative stress and double strand breaks in thymus cells
(Xu et al., 2016d). Therefore, we measured Mdr1 and Mrp1 mRNA expression and
activity to see if the differential sensitivities of DN and DP cells to As+3 induced toxicity
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were due to As+3 export. Our results demonstrate that the exporter activity in DN cells
was lower than in DP cells (Fig. 6.6B). Also, Mdr1 and Mrp1 mRNAs were not
significantly induced in DN cells after 18 h 50 and 500 nM As+3 in vitro treatments in
contrast to the DP cells. These results suggested that the high As+3 genotoxicity in DN
cells was due to increased exposure resulting from limited exporter induction.
In order to confirm that the high sensitivity of DN cells to As+3 was due to As+3
export, we measured the intracellular As+3 in sorted DN and DP cells treated with As+3
in vitro. The accumulation of intracellular As+3 levels was significantly higher in DN
cells than in DP cells at 18 h (Fig. 6.4), which may be the result of limited exporter
activity. Since we already confirmed from in vivo studies that intracellular As
accumulation was responsible for differential genotoxicity in cells from multiple immune
organs (Xu et al., 2016c), the higher As+3 accumulation in DN cells observed in this study
provided an explanation for why DN cells are more sensitive to As+3 induced toxicity
than DP cells. DN cells are also highly IL-7 dependent cells. Our previous findings
indicated that As+3 can suppress the IL-7 signaling pathway which cause cell cycle arrest
(Xu et al., 2016a). Therefore, the selective decrease in DN cell population after As+3
exposure may be the result of a combination effect of both genotoxicity and nongenotoxicity.
Mdr1 and Mrp1, also known as Abcb1 and Abcc1, are two ATP-dependent multidrug resistant proteins. As+3 is often used in the form of arsenic trioxide (ATO) to treat
different types of malignant diseases such as leukemia and cancers. Many studies have
demonstrated that certain malignant cells with high expressions of Mdr1 and Mrp1 were
resistant to ATO therapy (Seo et al., 2007; Sertel et al., 2012). In this study, we
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performed siRNA knockdown for both Mdr1 and Mrp1 in a mouse DN -T cell line to
confirm the association between Mdr1/Mrp1 expression and the genotoxicity. The
knockdown of Mdr1 and Mrp1 not only increased the DNA damage induced by As+3 in
D1 cells, but also decreased the cell viability after 18 h As+3 treatment (Fig. 6.9). These
results study show that the inhibition on these exporters specifically may enhance the
As+3 toxicity in certain type of cells. The effect of Mrp1 knockdown was much greater
than Mdr1 knockdown. Since Mrp1 export GSH-conjugated As+3, and Mdr1 export
unconjugated As+3, it is possible that most of the intracellular As+3 are GSH-bound and
need to be transported by Mrp1.
In summary, the study confirmed that As+3 selectively target DN thymus cells.
The greater sensitivity of DN cells compared to DP cells was a result of more
intracellular As+3 accumulation and therefore exposure. The expressions and induction of
two major As+3 exporters after As+3 treatments, Mdr1 and Mrp1, were found to be
responsible for the differential intracellular As+3 and genotoxicities. This is the first study
that clearly demonstrated a relationship between intracellular As+3 level and As+3
exporter activities and expressions, which suggested an explanation of how As+3
exporters regulate the As+3 induced toxicity in thymus cells at different stages.
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GENERAL DISCUSSION

Many studies revealed that arsenic induces immunotoxicity (Ahmed et al., 2014;
Biswas et al., 2008; Gonsebatt et al., 1994; Nadeau et al., 2014; Soto-Pen˜ a et al., 2006;
Vahter, 2008). However, few studies have ever addressed the toxicity induced by arsenic
in thymus cells from a mechanistic perspective. Early T cells in thymus are developing
from early DN stage to CD4 or CD8 SP cells. Most of the cells will die through apoptosis
during the positive and negative selections (Klein et al., 2014). Studies have indicated
that suppression of the early T cells could result in detrimental effects on immune
functions (Ohm et al., 2003; Seinen and Penninks, 1979). Since arsenic has been
demonstrated to alter immune functions and peripheral T cells (Dangleben et al.,2013), it
is possible that the suppressive effects of arsenic are due to its toxicity on the early
thymic T cells. This comprehensive study on arsenic induced toxicity in early thymic T
cells not only revealed the mechanism of how arsenic affects a certain type of early
immune progenitor cells, but also indicated a possible mechanism of arsenic induced
immunotoxicity in the body.
Many studies have focused on the immunotoxicity of arsenic at high
concentrations, which may not be representative of real environmental exposures.
Epidemiology studies have indicated that people consuming contaminated drinking water
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are usually exposed to arsenic up to several hundred ppb (Chowdhury et al., 2000).
Therefore, 500 ppb was selected as the high dose for the study in the in vivo experiments
in this project. The conversion of ppb doses of As+3 to nanomolar concentrations is 10
ppb ≈ 130 nM. The high dose in our in vitro treatments was 500 nM, which is in the same
range of intracellular arsenic amounts in the thymus cells after the 30 d high dose (500
ppb) in vivo exposure (Table 4.2). Therefore, the amounts of arsenic used in both the in
vivo and in vitro experiments in this study are close reflections of real environmental
conditions. The results from our studies are more environmentally relevant than most of
the other studies on arsenic immunotoxicity.
Previous studies have indicated that arsenic affects multiple systems (Argos et al.,
2010; Schuhmacher-Wolz et al., 2009; Vahter, 2008). In this study, the toxicity of arsenic
to early thymic T cells at environmentally relevant concentrations was assessed from both
genotoxic and non-genotoxic (cell signaling) aspects. Both pathways were confirmed by
experiments to be involved in the suppressive effects of arsenic to early thymic T cells. In
the genotoxicity study, As+3 exposures in vivo and in vitro caused increase of DNA
damage by the inhibition PARP1, the initiator of BER, at low concentrations (Xu et al.,
2016c). Oxidative stress was observed with the higher concentrations of As+3 in thymus
cells (Xu et al., 2016d). The dual-action model of As+3 genotoxicity was confirmed in
thymus cells at lower concentrations compared to the previous studies (Qin et al., 2008).
The suppressive effects of As+3 and MMA+3 on IL-7 signaling were observed in DN T
cells, which resulted in the decrease of cell cycle gene expression (Xu et al., 2016a). The
study results were similar to our previous studies in the early pre-B cells (Ezeh et al.,
2016). Taken together, these results indicated that arsenic induced toxicity in early
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thymus cells is a complicated phenomenon, which involves its actions on different
pathways.
Most toxicology studies are designed to focus on just one chemical. However, it is
not uncommon that people are exposed to multiple toxicants at the same time in
environmental conditions. Previous reports indicated that the co-exposures of arsenic
with other chemicals enhanced the toxicity and carcinogenesis (Burns et al., 2008;
Cooper et al., 2014; Maier et al., 2002). BaP is a ubiquitous contaminant that can be
found in wood and cigarette smoke, over-processed food and contaminated water
sources, the exposure of which is known to be related to the chimney sweeps' carcinoma,
a squamous cell carcinoma of the skin of the scrotum (Crawford, 1988). Previous studies
have demonstrated that the interaction between BaP and arsenic could enhance the
cytotoxicity and formation of adducts (Evans et al., 2004; Maier et al., 2002). The in vitro
co-treatment experiment of BP-diol and As+3 indicated that the environmentally relevant
low dose exposures could increase the toxicity of BP-diol and As+3 and induce apoptosis
in mouse thymus cells (Fig 5.3). The mechanism of these interactive effects involved
both accelerated metabolism of BP-diol to BPDE from the increased expression of
CYP1A1 and CYP1B1, and the inhibition of DNA damage repair by As+3.
Cells from different tissues were shown to have differential sensitivity to arsenic
(Burchiel et al., 2014; Chen et al., 2016; Rangwala et al., 2012). However, the
mechanism of the differential sensitivity is still not clear. Many studies on arsenic
trioxide (ATO) resistant tumor cells demonstrated that the overexpression of two As+3
exporters, Mdr1 and Mrp1, are responsible for the resistance of ATO treatment (Liu et
al., 2001; Liu et al., 2002). This study confirmed that the difference in Mdr1 and Mrp1
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expression correlated with alterations in intracellular As+3 levels in the thymus cells at
DN and DP stages. The sensitivity to As+3 in other types of cell may also be related to the
expression of these exporters.
In summary, this project is the first comprehensive study of the toxicity of arsenic
at environmentally relevant concentrations in early T cells in thymus that addressed both
genotoxicity and non-genotoxicity. The mechanism of the interactions between As+3 and
the metabolites of BaP on the genotoxicity to thymus cells was also revealed. The
differential sensitivity of thymic T cells at DN and DP stages to As+3 was also
mechanistically studied (Fig 7.1). The results will provided information for the evaluation
and prediction of arsenic induced toxicity in thymus cells from environmental exposures.
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Figure 7.1. Mechanisms of environmentally relevant concentrations of arsenic induced
thymic toxicity. Arsenic induces genotoxicity through the inhibition of DNA repair
(lower concentrations) and oxidative stress (higher concentrations). Inhibition of cell
signaling by arsenic decreases the expression of certain cell cycle gene(s). The
suppressive effects of arsenic on the thymus cells can interact with other environmental
contaminants. The genotoxicity induced by arsenic was shown to be regulated by arsenic
transportation.
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SUMMARY OF AIM 1 FINDINGS AND THEIR SIGNIFICANCE

Primary thymus cells isolated from 10-14 wks old male C57BL/6J mice and the
D1 cells were used to assess the genotoxicity induced by As+3 at 5-500 nM
concentrations in vitro. The dose range were chosen based on our preliminary studies on
low dose As+3 toxicity in immune cells and previous studies of immunosuppressions of
As+3 that mimicked environmental exposures (Ezeh et al., 2014; Kozul et al., 2008).
Observations in this study indicated for the first time that As+3 increased the DNA
damage in isolated primary thymus cells and the D1 cells after in vitro treatment of 50
nM As+3 for 4 and 18 h (Fig 2.1 and 2.2). Inhibition of PARP activity was confirmed to
contribute to the increase of DNA damage (Fig 2.2). Oxidative stress was observed only
at 500 nM As+3 concentration in D1 cells at 4 h time point, which was reversed at the 18
h later time point (Fig 2.3). Expressions of two As+3 exporters, Mdr1 and Mrp1, were
found to be associated with the oxidative stress and DNA damage increase. These results
confirmed the previously developed dual-action model of As+3 toxicity that inhibition of
DNA repair was related to genotoxicity at lower concentrations, and oxidative stress was
only involved at high concentrations (Qin et al., 2008; Zhou et al., 2011). However, the
thymus cells seemed to be more sensitive to As+3 induced genotoxicity than
keratinocytes, raising the question about the mechanism of the high sensitivity of thymus
cells. The mechanism of this high sensitivity of the early thymus cells was discussed and
evaluated in Aim 3.
Following the observation that DN T cells in the thymus were selectively targeted
by As+3 exposures (Fig 3.4A), IL-7 signaling pathway, the crucial cytokine signaling for
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DN cell survival and proliferation, was also studied. In vitro experiments revealed that
the STAT5 and JAKs phosphorylation was inhibited by As+3 and MMA+3, which was
similar to our previous findings in the IL-7 dependent pre-B cells (Ezeh et al., 2016). The
suppression of the IL-7 signaling pathway resulted in the decreased expression of cyclin
D1, an important cell cycle gene (Fig 3.4D). These results indicated another pathway of
arsenic induced suppression of the early thymic T cells, and provided the evidence of the
higher sensitivity of DN cells than DP cells.
Another significant observation in this study is the arsenic distribution and
speciation in three immune organs, bone marrow, spleen and thymus, after in vivo As+3
exposures. Bone marrow was found to be more sensitive to As+3 than spleen and thymus,
and spleen was the least sensitive among the three (Fig 4.1). After the in vivo As+3
exposures, thymus cells contained the highest amount of intracellular arsenic (Table 4.2).
The DNA damage increase was proportional to the As+3 dose increase in both the bone
marrow and thymus cells. MMA+3 was confirmed to be the most abundant arsenical
species in bone marrow and thymus cells (Table 4.2), indicating that the increased DNA
damage observed in the bone marrow and thymus at 500 ppb As+3 dose was caused by
MMA+3. These findings revealed that the differential sensitivity to arsenic in different
cells may be due to the intracellular arsenic levels and species. The study also confirmed,
for the first time, that MMA+3 was important for the arsenic induced toxicity in vivo.
In summary, these results from the study in Aim 1 confirmed the hypothesis that
As+3 could induce both genotoxicity and non-genotoxicity in mouse thymus cells. This
was the first comprehensive study on the arsenic induced toxicity in the early developing
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T cells in the thymus, and compared the differential sensitivities of the cells from three
important immune organs to arsenic.
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SUMMARY OF AIM 2 FINDINGS AND THEIR SIGNIFICANCE

Previous studies in our laboratory demonstrated that arsenic interacted with
DMBA and DBC at low concentrations to suppress immune cell functions (Ezeh et al.,
2015; Li et al., 2010). The present study was designed to reveal the mechanism of the
interactive effects between arsenic and PAHs. Several PAHs and their metabolites were
evaluated for their ability to inhibit PARP activation (Fig 5.1), and BaP and its
metabolites were selected as the model to study the interactive effects with As+3 at
environmentally relevant concentrations. Synergistic increase of DNA damage and PARP
inhibition were observed in As+3 + BP-diol treatments at low concentrations, with a
significant increase of cell apoptosis (Fig 5.2 and 5.3). As+3 and BP-diol co-treatment was
also found to up-regulate the expression of CYP1A1 and CYP1B1, two important
enzymes for the metabolism of BP-diol to BPDE (Fig 5.6).
These results clearly showed for the first time that BP-diol, an intermediate
metabolite of BaP, interacted with As+3 synergistically to increase the genotoxicity to the
primary thymus cells. The possible mechanism of the interactive effects was also
revealed from this study. BP-diol was metabolized into BPDE and formed DNA adducts
to increase DNA damage. As+3 inhibited PARP, the zinc finger DNA repair protein, so
that the DNA damage could not be properly repaired. The co-treatment of As+3 and BPdiol significantly increased the expression of CYP1A1 and CYP1B1, which accelerated
the generation of BPDE. The results confirmed our hypothesis in Aim 2, and provided a
possible mechanism of arsenic and PAHs interactions at environmentally relevant
concentrations.
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SUMMARY OF AIM 3 FINDINGS AND THEIR SIGNIFICANCE

Findings in Aim 1 and Aim 2 demonstrated that environmentally relevant
concentrations of arsenic could induce significant toxicity in mouse thymus cells. The
DN cells in thymus, the earliest subset of thymocytes, were found to be the most sensitive
among the DN, DP, CD4SP and CD8SP subsets. Besides the suppressive effects of
arsenic on the critical cytokine signaling pathway that is required for the development of
early progenitor cells, the bone marrow and thymus were also found to be more sensitive
than the spleen to As+3 and MMA+3 induced genotoxicity (Fig 4.1). The hypothesis that
the differential sensitivity was caused by the differences in arsenic transportation and
intracellular accumulation was evaluated in Aim 3.
DN and DP cell populations were separated by cell sorting, and As+3 induced
genotoxicity in DN was found to be more significant than in DP cells (Fig 6.2). More
intracellular As+3 accumulation in DN cells than DP cells was confirmed by HG-CT-ICPMS analysis (Fig 6.4). The lack of the expressions of two major As+3 exporters, Mdr1 and
Mrp1, were found to be associated with the high sensitivity of DN cells to As+3.
Knockdown experiments in D1 cells confirmed that Mdr1 and Mrp1 expressions were
related to As+3 accumulation and toxicity (Fig 6.9). These results demonstrated for the
first time that lack of As+3 exporter expression could result in higher As+3 toxicity in
certain types of cells. The study confirmed the hypothesis that arsenic transportation
affected its toxicity, and provided a mechanism related to differential sensitivity to As+3
in different types of cells.
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OVERALL IMPACT OF THESE STUDIES AND POTENTIAL AREAS FOR
NEW STUDIES

This is the first comprehensive study on the toxicity induced by environmentally
relevant concentrations of arsenic on thymocytes. The study revealed both the genotoxic
and non-genotoxic effects of arsenic at low concentrations on the early thymic T cells.
The early T cells in thymus were found to be very sensitive to arsenic exposures.
Numerous studies have showed the strong relationship between arsenic exposure and T
cell immunosuppression in human and animal models. The toxicity induced by arsenic on
the early T cells may be the reason of the immunosuppression of the matured T cells.
The differential sensitivity to arsenic toxicity of different types of cells was
noticed before by many other studies. However, few studies have ever related the
sensitivity to the distribution of arsenic in vivo. In this study, the differential sensitivities
to arsenic in cells from bone marrow, spleen and thymus were compared and evaluated.
The intracellular arsenic amounts in the cells from the three immune organs from As+3
exposed mice were also analyzed. A proportional increase of DNA damage to the
increase of intracellular arsenic amounts was observed in cells from the bone marrow and
thymus, the two organs that were sensitive to environmentally relevant concentrations of
arsenic induced toxicity. Also, MMA+3 was confirmed to be the most prevalent form of
arsenic in the bone marrow and thymus cells, which provided supporting evidence for our
previous studies on the toxicity of MMA+3 in bone marrow pre-B cells (Ezeh et al.,
2014). More MMA+3 studies at the in vivo-relevant doses should be conducted in vitro to
examine the mechanism of MMA+3 induced toxicity in thymus cells in the future.
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The interactive genotoxicity of As+3 and BaP was reported before (Maier et al.,
2002). In this study, interactive genotoxicity of As+3 and BP-diol, the metabolite of BaP,
was observed in mouse thymus cells at lower concentrations. The mechanism of the
interactive genotoxicity was also revealed in detail. Since it is common to expose to
multiple contaminants at the same time in real environmental conditions, the study on the
low dose interactive effects between arsenic and BaP on the early thymic T cells provided
an example of how different environmental agents could interact with each other to
enhance the toxicity.
While more and more population-based studies, such as the Emory Health and
Exposome Research Center: Understanding Lifetime Exposures (HERCULES) project,
the Human Early-Life Exposome (HELIX) project in Europe, and the Health and the
Environment-wide Associations based on Large population Surveys (HEALS) project
founded by the European Union, are focusing on the interactive effects of multiple
environmental pollutants to the human body, most of the mechanistic studies in
environmental toxicology are still being conducted with a single chemical. The
complexity of the biological reactions induced by one chemical is a big limitation to the
study of interactive toxicity. However, our study confirmed that such kind study could be
conducted in certain mechanistically well-characterized chemicals based on carefullydesigned experiments and explicit hypothesis. It is predictable that more and more studies
focusing on the interactive effects of multiple chemicals will be conducted in the future.
The study also demonstrated for the first time that the toxicity of As+3 was
dependent on the transportation of As+3. Previous studies showed that certain malignant
cells with up-regulation of Mdr1 and Mrp1 were resistant to arsenic treatments (Liu et al.,
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2001; Liu et al., 2002). However, the key evidence for the relationship between the Mdr1
and Mrp1 over-expression and more arsenic efflux was not showed in these studies. The
present study revealed that high sensitivity of DN cells were due to the accumulation of
As+3 in the cells, which was related to the expression and up-regulation of the two As+3
exporters, Mdr1 and Mrp1. Knockdown of Mdr1 and Mrp1 in the D1 cells also confirmed
that the expressions of Mdr1 and Mrp1 were important for the exportation of As+3. These
results indicated a mechanism that could be responsible for differential sensitivity of
different types of cells to arsenic induced toxicity.
The Aim 1 part of this project confirmed the previously described mechanisms of
arsenic induced genotoxicity and non-genotoxicity in primary thymus cells. It also
demonstrated that the high sensitivity of thymus cells to arsenic induced toxicity was due
to the high intracellular accumulation of arsenic. The results from the Aim 1 provided
supporting evidence and ideas for the Aim 2 and Aim 3 part. The Aim 2 part of this
project revealed the mechanism of how the metabolites of BaP could interact with arsenic
synergistically to enhance the genotoxicity. The interactive effect was observed from the
in vitro treatment of BP-Diol and As+3 at extremely low concentrations. The activation of
the key enzymes for the metabolism of BP-Diol may also happen in in vivo conditions
and enhances the genotoxicity in human body in the real environmental exposures. The
mechanism also explained the previously described observations that the co-exposure of
arsenic and BaP significantly increased the BaP adducts in rats (Evans et al., 2004). The
Aim 3 part of the study was based on the observations from Aim 1, and provided a
mechanism of how cells at different stages of their development may have differential
sensitivity to arsenic induced toxicity. Previous observations indicated that certain types
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of cancers are resistant to As+3 treatments (Seo et al., 2007; Sertel et al., 2012). Since the
DN cells are more prone to As+3 induced apoptosis due to the limited activation of As+3
exporters, the As+3 resistance of these tumor cells may be the result of high exporter
expression. The results from Aim 3 part also provided the idea that quantification of the
real amount of exposure is very important in the future studies of arsenic toxicity.
Since arsenic exposure is a world-wide public health issue, this first
comprehensive study on arsenic induced toxicity in thymus cells will contribute to the
understanding of the whole picture of how the exposure can induce immunosuppression
in human body. The study on the mechanism of the toxicity and suppressive effects
induced by arsenic on the early developing T cells may potentially benefit the
populations in the arsenic contaminated areas to prevent the dysfunction of the immune
system and many other types of diseases associated with arsenic exposure.
The experimental models of the project were based on the thymus cells from
C57BL/6J mice. The doses and treatment concentrations applied in the studies were
selected based on environmental conditions. However, just like many other controlled
exposure studies in laboratory using inbred animal models, the real environmental
exposures in humans may have different effects. There are some population-based studies
conducted in in utero exposed kids as mentioned in Chapter 1, but more evidence from
epidemiology studies in adults is also required to compare the experimental results and
clinical findings. Therefore, future studies with human samples from exposed individuals
should be also performed to provide evidence for safety evaluation and assessment.
Based on the results of the study, the following questions should be addressed in
the follow-up studies:

180



What is the genotoxicity induced by MMA+3 in thymocytes? – Based on the findings
in Aim 1 that the most prevalent arsenic species in thymus cells after in vivo As+3
exposure was MMA+3, the genotoxicity of MMA+3 should be conducted in vitro to
connect the in vivo and in vitro findings.
 Possible study: DNA damage and PARP activity in thymus cells after
MMA+3 exposures.
 Possible study: Oxidative stress and DSBs in thymus cells after MMA+3
exposures at different time points.



Is there selective toxicity in DN1 to DN4 subsets? – DN cells can be differentiated
into DN1 to DN4 subsets. Previous study indicated that cadmium altered the DN1
and DN2 populations after in vivo exposures (Holásková et al., 2012). Arsenic may
also selectively target certain subsets in DN cells.
 Possible study: Flow cytometry study using CD25, CD44 or CD127R cell
surface markers to evaluate the changes in DN1 to DN4 cell populations after
in vivo and in vitro exposures to As+3.



What are the effects of As+3 and BP-diol interactions in vivo? Are there more PAHs
that interact with arsenic? – In Aim 2, we demonstrated that As+3 interacted with BPdiol in vitro to increase the DNA damage and apoptosis in thymus cells. Whether the
similar interactions can happen in vivo should be studied. The interactions between
As+3 and other PAHs could also be addressed in future studies.
 Possible study: Co-exposure of low dose As+3 and BP-Diol in C57BL/6J
mice; Cell recovery, DNA damage and PARP activity studies in thymus cells.
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 Possible study: Co-treatments of As+3 and other PAHs in vitro; DNA damage,
PARP activity, apoptosis studies.


What are the effects of arsenic exposure on the immune cell populations and
functions in humans? – The study was conducted in inbred mouse models. More
evidence should be provided by population-based studies in humans for a better
understanding of the effects in real environmental conditions.
 Possible study: Flow cytometry study on human PBMC samples from arsenic
exposed individuals using immune cell surface markers, including the
specific markers for T cells, such as CD3, CD4 and CD8.
 Possible study: Flow cytometry study on human PBMC samples using IL-7R
marker for early and memory T cells.
 Possible study: mitogenesis assay using Concanavalin A to study the
proliferation of T cells from arsenic exposed individuals.



Is there an interactive effect between arsenic and other heavy metals in the
environment, such as uranium? – It is very common that other heavy metals, such as
cadmium, lead or uranium, present together with arsenic in contaminated drinking
water sources. Therefore, the potential interactions between these heavy metals
should be examined.
 Possible study: DNA damage and PARP activity in thymus cells after
As+3/MMA+3 and uranium combined exposures at environmentally relevant
doses.
 Possible study: Oxidative stress and DSBs in thymus cells after As+3/MMA+3
and uranium combined exposures at different time points.
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LIST OF ABREVIATIONS

2-ME

2-mercaptoethanol

3-MC

3-methylcholanthrene

AAALAC

Association for Assessment and Accreditation of Laboratory Animal Care

Ab

Antibody

ABCB

ATP binding cassette subfamily B member

ABCC

ATP binding cassette subfamily C member

AhR

Ayl hydrocarbon receptor

ANOVA

Analysis of variance

ANTH

Anthracene

AO/PI

Acridine Orange/Propidium Iodide

APC

Accessory photosynthesis Pigment of the Cyanobacteria

APC

Antigen presenting cell

AQP

Aquaglyceroporin

As

Arsenic

As+3

Arsenite

As+5

Arsenate

AS3MT

Arsenite methyltransferase

BA

Benz(a)anthracene

BaP

Benzo(a)pyrene

BCA

Bicinchoninic acid

BeP

Benzo(e)pyrene
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BM

Bone Marrow

BP-diol

Benzo(a)pyrene-7,8-dihydrodiol

BPDE

Benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide

Caspase

Cysteinyl aspartate-specific proteases

CD

Cluster of differentiation

CYP

Cytochrome P450

CYP1A1

Cytochrome P450 1A1

CYP1B1

Cytochrome P450 1B1

cDNA

copy Deoxyribonucleic acid

DAC

Dibenz(a,c)anthracene

DAH

Dibenz(a,h)anthracene

DBC

Dibenzo[def,p]chrysene

DC

Dendritic Cell

DHE

Dihydroethidium

DMA

9,10-Dimethylanthracene

DMA+3

Dimethylarsonous acid

DMA+5

Dimethylarsinic acid

DMBA

7, 12-Dimethylbenz[a]anthracene

DMBA-diol Dimethylbenz[a]anthracene-trans-3,4-dihydrodiol
DN

Double Negative

DP

Double Positive

DPBS

Dulbecco’s Phosphate Buffered Saline

DPBS-

Dulbecco’s Phosphate Buffered Saline without calcium and magnesium
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DSBs

Double strand breaks

EDTA

Ethylenediamine teraacetate acid

FBS

Fetal bovine serum

FITC

Fluorescein Isothiocyanate

FL

Fluorescence channel

FSC

Forward Scatter

GAPDH

Glyceraldehyde-3-Phosphate Dehydrogenase

HBSS

Hanks Balanced Salt Solution

HPBMC

Human Peripheral Blood Mononuclear Cell

HSC

Hematopoietic Stem Cell

HRP

Horse Radish Peroxidase

IARC

International Agency for Research on Cancer

IAUCC

Institutional Animal Care and Use Committee

Ig

Immunoglobulin

IgG

Immunoglobulin G

IFN-γ

Interferon gamma

IL

Interleukin

IL-7

Interleukin-7

IL-7R

Interleukin-7 receptor

JAK

Janus Kinase

kD

kilo Dalton

mAb

monoclonal antibody

Mdr

Multidrug resistance protein
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Mrp

Multidrug resistance-associated protein

µl

microliter

MMA+3

Monomethylarsonous acid

MMA+5

Monomethylarsinic acid

mRNA

messenger Ribonucleic acid

NK

Natural Killer cell

ng

nanogram

NIH

National Institutes of Health

PAGE

Polyacrylamide gel electrophoresis

PAHs

Polycyclic Aromatic Hydrocarbons

PARP

Poly (ADP-ribose) polymerase

PAX5

Paired Box-containing transcription factor 5

PCR

Polymerase Chain Reaction

PE

Phycoerythrin

PE-Cy7

Phycoerythrin-Cyanine7

PI

Propidium Iodide

ppb

parts per billion

ppm

parts per million

pSTAT5

phosphorylated STAT5

pJAK1

phosphorylated JAK 1

qPCR

quantitative Polymerase Chain Reaction

RPMI

Roswell Park Memorial Institute

RIPA

Radioimmunoprecipitation assay
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RNS

Reactive nitrogen species

ROS

Reactive oxygen species

SDS

Sodium dodecyl sulfate

STAT

Signal Tranducer and Activator of Transcription

TCDD

2,3,7,8-terachlorodibenzo-p-dioxin

TDAR

T-Dependent Antibody Responses

UV

Ultraviolet light

UVR

Ultraviolet light radiation

Zn

Zinc
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